UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

10351 Santa Monica Blvd., Suite 420

Los Angeles, CA 90025

(Address of principal executive Office) (Zip Code)

877-730-7463

(Registrant’s Telephone Number)

Copies to:

Jonathan Shechter, Esq.

Sasha Ablovatskiy, Esq.

Foley Shechter LLP

211 East 43 ^rd Street, 7 ^th Floor

New York, New York 10017

(212) 335-0465

(917) 688-4092 (facsimile)

Securities to be registered under Section 12(b) of the Act:

Securities to be registered under Section 12(g) of the Act:

Common stock, $0.0000001 par value per share

(Title of class)

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

TABLE OF CONTENTS

Special Note Regarding Forward-Looking Statements

This Registration Statement on Form 10 (this “Form 10”) contains forward-looking statements within the meaning of the U.S. federal securities laws, which involve substantial risks and uncertainties. The forward-looking statements are contained principally in the sections entitled “Business,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. These risks and uncertainties include, but are not limited to, the factors described below in the section captioned “Item 1A. Risk Factors.”

In some cases, you can identify forward-looking statements by terms such as “anticipates,” “believes,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “would” and similar expressions intended to identify forward-looking statements. Forward-looking statements reflect our current views with respect to future events and are based on assumptions and are subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements.

Forward-looking statements represent our estimates and assumptions only as of the date of this Form 10. You should read this Form 10 and the documents that we filed as exhibits to this Form 10, completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of the forward-looking statements by these cautionary statements. Except as required by law, we assume no obligation to update any forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in any forward-looking statements, even if new information becomes available in the future.

Trademarks, Service Marks and Trade Names

This Form 10 contains references to our trademarks, service marks and trade names and to trademarks, service marks and trade names belonging to other entities. Solely for convenience, trademarks, service marks and trade names referred to in this Form 10, including logos, artwork and other visual displays, may appear without the ^® or ^TM symbols, but such references are not intended to indicate, in any way, that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto. Except as set forth in this Form 10, we do not intend our use or display of other companies’ trade names, service marks or trademarks or any artists’ or other individuals’ names to imply a relationship with, or endorsement or sponsorship of us by, any other companies or persons.

Item 1. Business.

Corporate History

Pineapple Express, Inc. (together with our wholly owned subsidiaries, the “Company,” “we,” “us” or “our”) was originally formed in the state of Nevada under the name Global Resources, Ltd. on August 3, 1983. The Company changed its name to “Helixphere Technologies Inc.” on April 12, 1999 and to “New China Global Inc.” on October 2, 2013. The Company reincorporated in Wyoming on October 30, 2013 and changed its name to Globestar Industries on July 15, 2014. On August 24, 2015, the Company entered into a share exchange agreement with Better Business Consultants, Inc. (“BBC”) (dba “MJ Business Consultants”), a corporation formed in state of California on January 29, 2015, all of BBC’s shareholders, and the Company’s majority shareholder (the “ Share Exchange ”). Upon the consummation of the Share Exchange, BBC became a wholly owned subsidiary of the Company, the Company ceased its prior business of providing educational services and continued the business of BBC as its sole line of business. On September 3, 2015, the Company changed its name to “Pineapple Express, Inc.” BBC currently has two wholly owned subsidiaries, Pineapple Express One LLC, a California limited liability company, and Pineapple Express Two LLC, a California limited liability company. BBC’s former subsidiary, Pineapple Property Investments, LLC, was dissolved on April 18, 2016.

On February 12, 2016, the Company entered into an Agreement of Merger to acquire all of the assets and, except for those undisclosed liabilities specified in section 3.6 of the Agreement of Merger, assume all the liabilities of THC Industries, Inc., a California corporation (“THC Parent”), through a two-step merger by and among the Company, THC Parent, the Company’s wholly owned subsidiary THC Industries, LLC, a California limited liability company (“THC”), and the Company’s former wholly owned subsidiary THC Merger Co., Inc., a California corporation (the “THC Merger”). The transaction was delayed and on June 22, 2017the Company successfully completed the conditions of a Standstill and Waiver Agreement signed between the parties on March 27, 2017, which resulted in a transfer and ownership of the assets relative to the purchase transaction. As a result of the THC Merger, THC became the Company’s wholly owned subsidiary.

On March 14, 2017, the Company entered into a Share Purchase Agreement (the “Share Purchase Agreement”) to sell BBC and its two wholly owned subsidiaries, Pineapple Express One LLC and Pineapple Express Two LLC to, Jaime Ortega, the Company’s largest shareholder and a related party, so that he can fund and prosecute litigation claims and settle debts for such subsidiaries, resulting from unconsummated parcel purchases the Company feels was purposely circumvented by 3 ^rd parties involved in those transactions. Mr. Ortega took these steps so the Company’s claims can be addressed against the parties at fault without negatively impacting or distracting the Company. The terms of the Share Purchase Agreement are discussed in greater detail below in the section captained “Legal Proceedings” of this Registration Statement on Form 10.

On March 16, 2017, the Company formed Pineapple Express Consulting, Inc. (“PEC”) as a wholly owned subsidiary. Yucca Road Lease, LLC (“YRL”), a California limited liability company, formed by Sky Island, the owner of whom is the Company’s largest shareholder, on June 27, 2017 for the purpose of leasing or acquiring properties in the Yucca Road area of Adelanto, CA for purposes of advancing the business objective of the Company. On July 12, 2017, Sky Island changed the name of YRL to Pineapple Park, LLC (“PP”). On August 3, 2017, PP was conveyed to the Company by Sky Island for $100,000 an amount Sky Island had already paid as a deposit to Adelanto Property Management, LLC against a “master lease” for the Yucca Road premises at 10007-10019 Yucca Road, Adelanto, CA 92301. This $100,000 deposit was added to the debt owed by the Company to Sky Island, in essence, acquiring PP for no consideration. During the course of PP’s ownership by Sky Island, Sky Island also formed Pineapple Ventures Inc. (“PVI”), which entity applied for a permit from the City of Adelanto for commercial cannabis cultivation and manufacturing activities at the leased site. Once, and if, this application is approved, the Company has an option to purchase PVI from Sky Island for $1,000,000. As of the date of this filing, the applied for permit has not been granted nor has management indicated its intention to exercise the purchase option.

Overview

Through our operating subsidiary PEC, we provide capital to our canna-business clientele and provide consulting services and technology to develop, enhance, and expand existing and newly formed canna-businesses. Through PP, we develop, lease, and manage real estate properties for the use of PEC canna-business clients of PEC. Through our operating subsidiary THC, we operate a branded clothing line and own the rights to sell apparel such as t-shirts, hats, beanies, pants, shorts, baseball jerseys, jackets, sweatshirts, polo shirts, sweat pants and other attire displaying the THC trademarked name and logo, operate a clothing distribution facility and own the rights to the THC.com URL address. In connection with the THC Merger, Ramsey Salem, the former Chief Executive Officer of THC Parent, joined us as the new Chief Executive Officer of THC in February 2016 and agreed to serve in this position for a period of five years, although his position with THC involves no policy making authorities for or on behalf of PNPL

We also intend to create a nationally branded and vertically integrated chain of cannabis retail stores under the “Pineapple Express” brand, which will be supported by anticipated Company-owned cultivation and processing facilities, and will feature products from anticipated Company-owned manufacturers. Our goal is that within five years the chain will consist of five Company-owned and operated facilities, and 20 licensee-owned cannabis retail stores. Currently our operations are limited to investing in existing and new canna-businesses, leasing real property to canna-businesses, consulting, product licensing, leasing and selling industry specific technology, and providing ancillary support services. However, we are currently in the process of transitioning to operating our own city and state licensed cannabis production, manufacturing, and distribution facility in Adelanto, CA within the next 6 months.

Companies in the cannabis industry face unique challenges and risks. To mitigate these risks, we operate both as an operating business and as a business that invests in other entities. It is our intention that this strategy will enable us to quickly develop recurring and easily replicable revenue sources, and avoid large upfront investments in infrastructure, escalating payroll costs associated with expansion, and the years of initial losses often typical of start-up companies. We believe that our competitive advantages include our business model, our exclusive proprietary technology, our employees’ and consultants’ extensive experience, and our key industry contacts in an industry that is both new and foreign to most. It is our expectation that these factors will set us apart from most of our competitors.

Business Strategy

We believe that due to the highly-fragmented nature of the existing cannabis industry, a vertically integrated supply chain will provide a sustainable competitive advantage over competitors, allow faster growth, more consistent product offerings, and make Pineapple Express more attractive for prospective licensees. Our revenues and profitability may be adversely affected by economic conditions and changes in the market for medical and recreational marijuana. Our business is also subject to general economic risks that could adversely impact the results of operations and financial condition ( see Risk Factors).We discuss each facet of our strategy below.

Retail Opportunities and Challenges

As of the date of this registration statement, management believes there are no nationally branded retail cannabis chains, though numerous entrepreneurs have announced plans to create such chains. We expect that the nationally branded chains that will be successful will either find long-term success in the retail environment, or will discover a financially attractive exit when the inevitable acquisition and consolidation phase sweeps the industry. Fortunately, that phase is some time away and will be dependent, at least in part, upon changes to existing federal laws and classifications. We believe that this creates an exceptionally unique opportunity for experienced and focused management teams to develop a national presence. Of particular importance and a distinct barrier to entry for the average entrepreneur is the importance of personal contacts, knowledge, and processes necessary to carry out project goals in an industry that is foreign to most. Management’s extensive experience and contacts set the Company apart from most of its competitors.

Due to a lack of established major national chains, there are only local competitors and currently there is no risk of encountering a larger corporation as our competitor. It is our belief that a variety of federally enforced rules and regulations make participation by existing national healthcare chains such as CVS Health Corporation, The Walgreen Company, Target Corporation’s pharmacies or Wal-Mart’s pharmacies unlikely.

Developing retail facilities from the ‘ground-up’ is a challenge in the cannabis industry. For example, stores must be licensed, which generally involves a costly, complex and time consuming process. Several jurisdictions have imposed strict limits on the number of licenses that may be issued. The present nature of cannabis in the national legislative realm has resulted in very strict zoning requirements for these types of businesses. These licensing hurdles translate into slow organic growth.

Our business model involves our Company (a) funding established businesses in need of capital to expand where the Company may enjoy an eventual control option on the business (e.g. capital is invested in the business keeping the current owner focused on growth), (b) funding teams of industry professionals that are in the process of developing a new operation and are in need of guidance and capital; and to a more limited degree, and(c) establishing Company owned stores from scratch. Management believes there are many obstacles to creating a robust and profitable national chain and at present direct store development will not be the most efficient path to success in the current cannabis environment. Management believes approaching growth in this manner will allow the Company to quickly generate revenue and reach sustainable profitability. We are looking to pursue additional transactions with retail and cultivation facilities, manufacturers, and distributors. Please see below section captioned “Initial Strategy Execution” for more information.

Retail Obstacles and the Pineapple Express Solution

One obstacle to a cross-border retail chain is producing and transporting the product. Due to existing federal laws, marijuana-based products cannot be transported across state lines. While cannabis remains illegal at the federal level, the federal government has by written policy set forth a safe harbor framework (see below section captioned “Government Regulation of Cannabis”) to allow the states limited independence to experiment with cannabis legalization in various forms. States have been careful to craft their local regulations to not run afoul of interstate transportation restrictions. State regulations generally require that cannabis must be grown locally (some states require retailers to grow their own product) and that cannabis-related products, including marijuana-infused edibles, oils, lotions, or salves, cannot be transported across state lines. For larger manufacturers, state regulations generally require establishing local manufacturing in each state; this translates to securing a local state-issued license, a challenging task in jurisdictions with limited licenses. The alternative approaches to establishing cross-border retain chains are either through contract manufacturing or licensing. These approaches create challenges with product consistency and the complications for the manufacturer of managing so many relationships and monitoring quality. Pineapple Express management has found an opportunity in the obstacle.

Marketing and Promotion

We strive to establish brand objectives, identify promotional strategies, and execute publicity and marketing plans to ensure the Company’s place in the cultural conversation. Our goal is to connect with consumers on a national level through advertising, marketing, and strategic alliances, in order to create brand awareness for the Pineapple Express and THC brands. Our publicity and marketing initiatives include specific strategies for national television, billboards, print media (magazines and newspapers), social media, exhibitions at industry trade shows, and local grassroots marketing efforts.

Consulting Services

Through PEC we will provide third parties consulting, licensing, development, and compliance services for the cannabis businesses and operational guidance in dispensary management.

Management’s experience in this sector allows PEC to provide greater value to clients in need of capital than traditional investment firms that have no industry related operating experience. This experience also allows us to have a long-term operational focus when we invest compared to the “buy-hold-sell” focus of typical private equity firms.

Initial Strategy Execution

We have developed a pipeline of opportunities, completed certain strategic transactions and have entered into certain agreements with respect to our business operations, as more fully discussed below:

Acquisition of THC Industries, a Branded Clothing Line and Website . On February 12, 2016, the Company acquired the business and assets of THC Parent, the web domain www.thc.com, and the trademark THC®. THC Parent was an operating business since its incorporation in California in 1996, making it one of the first internet based cannabis related businesses in the nation. The acquisition includes the THC.com URL address, the THC branded clothing line, use of a clothing distribution facility, and the rights to sell clothing, namely T-shirts, hats, beanies, pants, shorts, baseball jerseys, jackets, sweatshirts, polo shirts, and sweat pants displaying the THC trademarked name and logo.

In connection with the THC Merger, Ramsey Salem, the former Chief Executive Officer of THC Parent, joined us as the new Chief Executive Officer of THC in February 2016 and agreed to serve in this position for a period of five years. We acquired the THC business for consideration consisting of (i) a cash payment in the amount of $400,000, (ii) 2,275,133 shares of our common stock and (iii) a $600,000 promissory note secured by all of the purchased intellectual property that is payable in two equal installments on the 60 day and 90 day anniversaries of closing. On June 22, 2017, the Company paid all amounts due under the THC purchase agreement. The THC Parent shareholders have the option to require the Company to purchase from them up to 1,478,836 shares at a price of $0.68 per share from February 12, 2018 through August 12, 2018; provided however that they may only exercise this option if, for a 90 day period, the Company’s stock price is both less than $0.88 and the average daily trading volume is below 50,000 shares.

In July 2016, we entered into a licensing agreement with The Sharpe Company (“ Sharpe ”) to develop brand strategy, positioning, and lifestyle merchandise for the THC brand. In partnership with Sharpe, the Company has updated THC’s catalog of products and added new products.

In June 2017, the Company entered into a transaction whereas it licensed the THC.com website to The Hit Channel, Inc. (“Licensee”) that has agreed to develop the website and pay an initial licensing fee of $150,000 and a revenue sharing arrangement thereafter, subject to annual minimum amount guaranteed for the life of the contract. The THC.com website is expected to re-launch in fourth quarter of 2017.

In June 2017, the Company licensed its THC trademark to Putnam Accessory Group, Inc. (“PAG”), a leading accessory design, product development, production and logistics company for private label and branded fashion, under a royalty arrangement. PAG specializes in young men’s, women’s and junior’s headwear, cold weather beanies, scarves, gloves, an array of both fashion and technical bags as well as small accessory items. Established in 1997, PAG is a global organization with multiple office locations: worldwide headquarters in Los Angeles, showrooms in San Diego, Colorado and Japan, as well as manufacturing offices located throughout mainland China. The royalty arrangement obligates PAG to pay the Company 12% of sales during an 18-month engagement and also calls for royalty guarantee payments during subsequent renewal terms. In producing apparel and accessories with the THC trademark, PAG will be utilizing the THC style guide created by the Company, and the Company will be approving any and all uses of the trademark on a going forward basis.

Investment in Dispensary in Illinois . On January 27, 2016, we announced that our client, Nature’s Treatment of Illinois (“ NTI ”), became one of the first licensed medical cannabis dispensaries in Illinois. NTI is now able to engage in the distribution of cannabis for medical use in Illinois and will be the only medical marijuana dispensary in Illinois’ District 7. In January 2016 we entered into a management and consulting agreement with NTI, and as part of this agreement our subsidiary BBC assisted NTI with a rigorous conditional registration approval process and recent inspection. Also, we agreed to advise NTI on an ongoing basis with respect to its business strategy, day-to-day operations and dispensary license renewals. The agreement provides that we will receive compensation equal to the lesser of 5% of NTI’s gross profit or 15.18% of the after-tax distributable income of NTI. The management and consulting agreement has a five year term with an automatic five year renewal period unless terminated upon 30 days’ notice prior to end of current term by either party. PEC assumed this consulting agreement in conjunction with BBC being sold.

Effective November 14, 2017, all PNPL equity interests in NTI have been sold to the original NTI shareholder group for $150,000, however, NTI has entered into a new five year consulting agreement with PEC commencing January 1, 2018 under terms and conditions substantially identical to the prior management and consulting agreement. PNPL has the right to re-acquire the equity interests in NTI for a period of 120 days after the November 14, 2017 agreement, at a price of $200,000.

Through PP, the Company has leased 107,000 square feet of permitted commercial cultivation warehouse space in Adelanto, CA so it can sublease the same at a profit to its clients and tenants in Southern California. The Company has subleased approximately 34,000 square feet and plans to lease its remaining 73,000 square feet to new and existing clientele. We refer to such leasing activities in this Form 10 as the ““Pineapple Park” Development Project”

The Company has received a patent issued on May 9, 2017 from the USPTO for its proprietary Top-Shelf SDS (“Safe Display System”) for use in legally permitted cannabis dispensaries across United States and internationally, where permitted by law. On March 12, 2016, the Company signed a Software Integration Agreement with Leaf Logix Technology, a software solutions provider, to the legal cannabis industry, to interface directly with its Top-Shelf SDS hardware component to provide extensive Point-of-Sale solutions to the Company’s clientele. Leaf Logix Technology has over 100 canna-business customers spanning 12 states nationwide. Leaf Logix Technology offers custom compliance modules in cultivation, processing, and dispensary business activities. Pineapple Express will be utilizing the Top-Shelf SDS in conjunction with the Leaf Logix Technology software platform in every geographic area the Company focuses on in the future. The Company has begun developing the prototype and expects to begin sales in early 2018.

Research and Development

Going forward, we intend to increase our spending and resources for research and development. Allocation of research and development funds may be dependent on the perceived likelihood of legalization or a significant change in the treatment of cannabis in a given geographic market. Funds may also be used for both product and market development in the hemp and cannabis industries. Given the emergent nature of these industries, we recognize the needs of today may not be the needs of the future and some capital investment will be necessary to meet changing demands.

Trademarks and Intellectual Property

Following the THC Merger, we own the THC® trademark and domain rights to the “thc.com” URL address. A trademark application was filed by Global Brand Consulting LLC for a logo including the word “THC” (the “Conflicting Trademark”) with the USPTO. We believe that this application should have been rejected by the USPTO in light of the existing registered THC® trademark and that any use in commerce of the Conflicting Trademark by Global Brand Consulting LLC would be an infringement upon our trademark. We and the THC shareholders have agreed to hold in escrow $150,000 of the purchase price paid to the THC shareholders for use in connection with resolving this trademark dispute. The $150,000 has since been disbursed to the THC shareholders to satisfy the final THC Industries purchase by the Company. On June 15, 2016, we delivered a cease and desist letter to Global Brand Consulting LLC in connection with the foregoing. The Company has not yet initiated a lawsuit to pursue any infringement claims we might have with regard to the THC trademark.

We have filed trademark applications for our logos and trademarks for “Pineapple Express” and “Pineapple Express PuR” products with the United States Patent and Trademark Office.

Our intellectual property also includes our management’s knowledge and know-how relating to the legalized growth, production, manufacture, marketing, management, utilization and distribution of medical and recreational marijuana and marijuana infused products.

In August 2015, we acquired the provisional patent application for the Safe Display System from the developer of the product, for 1,000,000 shares of our Series A Preferred Stock. The system allows for a dispensary operator to safely display product, secure product in an armored safe, weigh product in real-time using electronic scales housed in each of the locked compartments within the safe, and then dispense the product using an integrated Point-of-Sale, or POS System. On July 20, 2016, we entered into a licensing and royalty agreement with the developer of the “Top-Shelf” (“Assignor”), which assigned us the patent application in question and provided for a royalty arrangement with Assignor pursuant to which (i) we shall pay Assignor a one-time royalty payment equal to 30% of the gross sales price of each unit sold, and (ii) if a system is leased, we shall pay Assignor 30% of any lease payments made to the Assignee. On May 9, 2017 the USPTO published the approved patent (No. 9,642,476) for the “Top-Shelf” system.

Employees and Independent Contractors

As of December 31, 2017, we had two part-time employees, and three full-time consultants, including two of our executive officers. We plan to hire additional employees and engage consultants on an as-needed basis. Our employees are not represented by any unions and we consider our relationship with our employees to be good. We also have relationships with several independent contractors who provide services on a regular basis to us.

Competition

We compete in markets where cannabis has been legalized and regulated, which includes various states within the United States. We expect that the quantity and composition of our competitive environment will continue to evolve as the industry matures. Additionally, increased competition is possible to the extent that new states and geographies enter the marketplace as a result of continued enactment of regulatory and legislative changes that de-criminalize and regulate cannabis products. We believe that by diligently establishing and expanding our brands, product offerings and services in new and existing locations, we will become established in the industry. Additionally, we expect that establishing our product offerings in new and existing locations are factors that mitigate the risk associated with operating in a developing competitive environment. Additionally, the contemporaneous growth of the industry as a whole will result in new customers entering the marketplace, thereby further mitigating the impact of competition on our operations and results. To our knowledge, as of the date of this Form 10 there are no nationally branded dispensaries, but we may face competition with respect to our consulting services.

Novus Acquisition & Development Corp. (“Novus”). Novus focuses on offering consulting services to the medical marijuana market in states where medical marijuana is legalized. Novus also offers healthcare coverage for marijuana-related products that are not covered by standard healthcare programs.

American Cannabis Company, Inc. (“ACC”). ACC offers consulting services as well as products, and helps plan for a project’s business model, including development of its operations and management practices. It also assists with application for licenses at the local and state level.

AmeriCann, Inc. AmeriCann develops cannabis cultivation facilities and provides capital for cannabis entrepreneurs in the State of Illinois. It also provides capital for the acquisition of land, working capital and construction for facilities.

United Cannabis Corporation (“UCANN”) . UCANN manages and invests in a group that has obtained provisional licenses for cultivation, production and processing of cannabis in Las Vegas, Nevada. It intends to offer products and services to dispensaries in the Las Vegas market.

We do not expect to face competition with respect to our “THC” branded apparel, however, other corporations may sell apparel that incorporates other logos or trademarks associated with the cannabis industry.

Government Regulation of Cannabis

Cannabis is currently a Schedule I controlled substance under the Controlled Substances Act (21 U.S.C. § 811) (“CSA”) and is, therefore, illegal under federal law. Even in those states in which the use of cannabis has been legalized pursuant to state law, its use, possession or cultivation remains a violation of federal law. A Schedule I controlled substance is defined as one that has no currently accepted medical use in the United States, a lack of safety for use under medical supervision and a high potential for abuse. The U.S. Department of Justice (the “DOJ”) defines Schedule I controlled substances as “the most dangerous drugs of all the drug schedules with potentially severe psychological or physical dependence.” If the federal government decides to enforce the CSA, persons that are charged with distributing, possessing with intent to distribute or growing cannabis could be subject to fines and/or terms of imprisonment, the maximum being life imprisonment and a $50 million fine, even though these persons are in compliance with state law.

In light of such conflict between federal laws and state laws regarding cannabis, the previous administration under President Obama had effectively stated that it was not an efficient use of resources to direct federal law enforcement agencies to prosecute those lawfully abiding by state-designated laws allowing the use and distribution of medical cannabis. The new administration under President Trump has indicated that he will strongly enforce the federal laws applicable to cannabis. Any such change in the federal government’s enforcement of current federal laws could cause significant financial damage to us. While we do not currently directly harvest, distribute or sell cannabis, we may be irreparably harmed by a change in enforcement policies of the federal government ( see Risk Factors).

The Company and our licensed products will also be subject to a number of other federal, state and local laws, rules and regulations. We anticipate that our licensees and vendors will be required to manufacture our products in accordance with the Good Manufacturing Practices guidelines and will be subject to regulations relating to employee safety, working conditions, protection of the environment, and other items. The current administration has indicated that it will closely scrutinize the cannabis industry, in particular, recreational marijuana. Changes in laws, rules and regulations or the recall of any product by a regulatory authority, could have a material adverse effect on our business and financial condition.

The Cole Memo

Because of the discrepancy between the laws in some states, which permit the distribution and sale of medical and recreational cannabis, from federal law that prohibits any such activities, then DOJ Deputy Attorney General James M. Cole during the Obama administration, issued the Cole Memo concerning cannabis enforcement under the CSA. The Cole Memo guidance applies to all of the DOJ’s federal enforcement activity, including civil enforcement and criminal investigations and prosecutions, concerning cannabis in all states.

The Cole Memo reiterates Congress’s determination that cannabis is a dangerous drug and that the illegal distribution and sale of cannabis is a serious crime that provides a significant source of revenue to large-scale criminal enterprises, gangs, and cartels. The Cole Memo notes that the DOJ is committed to enforcement of the CSA consistent with those determinations. It also notes that the DOJ is committed to using its investigative and prosecutorial resources to address the most significant threats in the most effective, consistent, and rational way. In furtherance of those objectives, the Cole Memo provides guidance to DOJ attorneys and law enforcement to focus their enforcement resources on persons or organizations whose conduct interferes with any one or more of the following important priorities (the “Enforcement Priorities”) in preventing:

On January 4, 2017, the U.S. Attorney General Jeff Sessions rescinded the Cole Memo and restored the “rule of law.” Such rescission essentially shifts federal policy from the hands-off approach adopted under the Obama administration to allowing federal prosecutors across the U.S. to decide individually how to prioritize resources to crack down on pot possession, distribution and cultivation of the drug in states where it is legal. Furthermore, the Trump administration has previously indicated that it will pursue the enforcement of federal cannabis laws.

While we do not believe our current activities involve those enumerated in the Cole Memo, in light of the rescission of the memo by the current U.S. Attorney General, federal prosecutors will now have significant discretion on their interpretation of these priorities, and no assurances can be given that federal prosecutors will agree with our position. We therefore cannot provide assurance that our actions are in full compliance with the Cole Memo or any other state or federal laws or regulations. In addition, there is no guarantee that the current administration will not further change its policy regarding the strict enforcement of federal laws or the eight listed priorities.

We intend to conduct rigorous due diligence to verify the legality of all activities that we engage in and ensure that our activities do not interfere with any of the Enforcement Priorities set forth in the Cole Memo, as such may be modified by the current U.S. Attorney General and/or the U.S. federal government.

Real Estate Acquisitions

On October 12, 2016, the Company subsidiary’s rights under a purchase contract with United Pentecostal Church of Desert Hot Springs (“UPCDHS”) to purchase 3.78 acres and existing building structures was terminated by UPCDHS. The subsidiary was unsuccessful in recouping any of the $1.5 million in costs associated with deposits to UPCDHS towards the acquisition of the parcel as well as paid and unpaid development costs expended regarding the parcel. The subsidiary was attempting to resolve the matter in an amicable fashion with UPCDHS as well as the ultimate acquirer of the parcel that had gained the benefit of the development costs expended by the subsidiary in improving the value of the parcel as well as the conditional use permit tied to the real estate. As a result, the subsidiary was sold by us to a related party and our largest shareholder, Mr. Ortega. That related party and new owner of the subsidiaries has stated that he will address the matter with UPCDHS as well as the purchaser of the parcel, and also resolve any debts to vendors that went unpaid, through litigation. The Company has identified a more cost effective approach to its initial strategy of purchasing parcels that it then develops and leases to its clients. Instead, the Company has opted to lease existing structures and re-lease the same at a premium after licensing for cannabis related purposes has been secured and development of the interior of the rental spaces has occurred to provide the sub-tenant a suitable space for the business purpose.

On April 5, 2017, the Company entered into a real estate purchase transaction for a 1.26-acre parcel of land in Desert Hot Springs, CA that the Company intends to develop over the course of the next 24 months. The parcel purchase was finalized on July 24, 2017 for $700,000 and the Company took possession of the parcel. In order to finance this purchase, the Company borrowed $700,000 from a related party entity, Sky Island, Inc., controlled by our largest shareholder, Jaime Ortega.

Going Concern

We are dependent upon the receipt of capital investment and other financing to fund our ongoing operations and to execute our business plan. If continued funding and capital resources are unavailable at reasonable terms, we may not be able to implement our plan of operations. We may be required to obtain alternative or additional financing, from financial institutions or otherwise, in order to maintain and expand our existing operations. The failure by us to obtain such financing would have a material adverse effect upon our business, financial condition and results of operations.

Our financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. Our independent registered public accounting firm has included an explanatory paragraph in their report in our audited financial statements for the fiscal year ended December 31, 2016 to the effect that our losses from operations and our negative cash flows from operations raise substantial doubt about our ability to continue as a going concern. Our financial statements do not include any adjustments that might be necessary should we be unable to continue as a going concern within one year after the date that the financial statements are issued. We may be required to cease operations which could result in our stockholders losing all or almost all of their investment.

Item 1A. Risk Factors

An investment in the Company’s Common Stock involves a high degree of risk. An investor should carefully consider the risks described below as well as other information contained in this registration statement. If any of the following risks actually occur, our business, financial condition or results of operations could be materially adversely affected, the value of our Common Stock could decline, and an investor may lose all or part of its, his or her investment.

Risks Related to Our Company and Our Business

We have a limited operating history and operate in a new industry, and we may not succeed.

We have a limited operating history and may not succeed. We are subject to all risks inherent in a developing business enterprise. Our likelihood of continued success must be considered in light of the problems, expenses, difficulties, complications, and delays frequently encountered in connection with manufacturing specialty products and the competitive and regulatory environment in which we operate. For example, the cannabis industry is a new industry that may not succeed, particularly should the Federal government change course and decide to prosecute those dealing in medical or recreational cannabis. In such event, there may not be an adequate market for our products. As a new industry, there are few established players whose business models we can follow. Similarly, there is little information about comparable companies for potential investors to review in making a decision about whether to invest in the Company.

Potential investors should consider, among other factors, our prospects for success in light of the risks and uncertainties encountered by companies that, like us, are in their early stages. For example, unanticipated expenses, unexpected problems, and technical difficulties may occur and they may result in material delays in the operation of our business, in particular with respect to our new products. We may not successfully address these risks and uncertainties or successfully implement our operating strategies. If we fail to do so, it could materially harm our business to the point of having to cease operations and could impair the value of our Common Stock to the point investors may lose their entire investment.

We have incurred significant losses since our inception, have generated minimal revenues to date and anticipate that we will continue to incur significant losses for the foreseeable future; our auditors have included in their audit report for the fiscal year ended December 31, 2016 an explanatory paragraph as to substantial doubt as to our ability to continue as a going concern.

We have incurred significant net losses in each year since our inception, including net losses of $556,048 for the nine months ended September 30, 2017, and $8,596,968 and $1,188,108 for the fiscal years ended December 31, 2016 and 2015, respectively. As of September 30, 2017, we had an accumulated deficit of $10,341,124. We anticipate incurring additional losses until such time we can generate significant revenues, and/or reduce operating costs. To date, we have generated minimal revenues and have financed our operations exclusively through the sale of our equity and debt securities (including convertible securities). The size of our future net losses will depend, in part, on the rate of future expenditures and our ability to generate revenue. We expect to continue to incur substantial and increased expenses as we grow our business. We also expect a continued increase in our expenses associated with our operations as a currently reporting publicly-traded company. We may incur significant losses in the future for a number of other reasons, including unsuccessful acquisitions, costs of integrating new business and assets, expenses, difficulties, complications, delays and other unknown events. As a result of the foregoing, we expect to continue to incur significant losses for the foreseeable future and we may not be able to achieve or sustain profitability.

Our auditors have included in their audit report for the fiscal year ended December 31, 2016 a “going concern” explanatory paragraph as to substantial doubt as to our ability to continue as a going concern. Our ability to meet our total liabilities of $4,891,233 as of September 30, 2017, and to continue as a going concern, is dependent on us generating substantial revenues and/or obtaining adequate capital to fund operating losses until we become profitable. We may never achieve profitability, and even if we do, we may not be able to sustain being profitable. As a result of our going concern qualification, there is an increased risk that you could lose the entire amount of your investment in our company, which assumes the realization of our assets and the satisfaction of our liabilities and commitments in the normal course of business.

We will require approximately $2,000,000 over the next 12 months to fully implement our business plans and we may not be able to raise sufficient funds or generate sufficient revenues to complete our development activities or sustain operations.

As of September 30, 2017, we had a working capital deficit of $4,399,437 comprised of cash of $240, $7,771 in prepaid expenses, $50,000 in accounts receivable and $162,146 in deferred rental income, offset by $1,345,896 of accounts payable, $131,934 in accrued interest payable, notes payable due to related parties of $1,215,892, notes payable of $47,069, advances on agreements (short term) of $608,161 deferred revenue of $576,250, security deposit on a lease agreements of $170,680, deferred rent income of $1,974, and derivative liabilities of $521,738 against the put options associated with the THC acquisition. Our primary source of operating funds since inception has been cash proceeds from the private placements of our equity and convertible debt and proceeds from issuance of our short term notes. We intend to raise additional capital through private placements of debt and/or equity securities, but there can be no assurance that these funds will be available on terms acceptable to us, if at all, or will be sufficient to enable us to fully complete our development activities or sustain operations.

If we are unable to raise sufficient additional funds or generate sufficient revenue, we will have to develop and implement a plan to further extend payables, reduce overhead, or scale back its current business plan until sufficient additional capital is raised to support further operations. There can be no assurance that such a plan will be successful.

Uncertainty of profitability

Our business strategy may result in increased volatility of revenues and earnings. As we will only develop a limited number of products and services at a time, our overall success will depend on a limited number of products and services, which may cause variability and unsteady profits and losses depending on the products and services offered and their market acceptance.

Our revenues and our profitability may be adversely affected by economic conditions and changes in the market for medical and recreational marijuana. Our business is also subject to general economic risks that could adversely impact the results of operations and financial condition.

Because of the anticipated nature of the products and services that we offer and attempt to develop, it is difficult to accurately forecast revenues and operating results and these items could fluctuate in the future due to a number of factors. These factors may include, among other things, the following:

Cannabis remains illegal under federal law.

Cannabis is a categorized as a Schedule I controlled substance by the Drug Enforcement Agency and the United States Department of Justice and is illegal to grow, possess and consume under federal law. Even in those jurisdictions in which the use of medical cannabis has been legalized at the state level, its use remains a violation of federal law. The United States Supreme Court has ruled in United States v. Oakland Cannabis Buyers’ Coop. and Gonzales v. Raich that it is the federal government that has the right to regulate and criminalize cannabis, even for medical purposes. Therefore, federal law criminalizing the use of cannabis preempts state laws that legalize its use for medicinal or adult-retail purposes. Strict enforcement of federal law regarding cannabis would likely result in our inability to proceed with our business plan.

The previous Obama administration has effectively stated that it is not an efficient use of resources to direct federal law enforcement agencies to prosecute those lawfully abiding by state-designated laws allowing the use and distribution of medical cannabis. In furtherance thereof, on August 29, 2013, the Department of Justice provided guidance to all U.S. federal prosecutors with respect to the enforcement of laws regarding cannabis via the publication of a memorandum authored by former US Attorney General James M. Cole (the “Cole Memo”). The Cole Memo stated that enforcement should be focused on eight priorities, which is to prevent: (1) distribution of cannabis to minors; (2) revenue from sale of cannabis to criminal enterprises, gangs and cartels; (3) transfer of cannabis from states where it is legal to states where it is illegal; (4) cannabis activity from being a pretext for trafficking of other illegal drugs or illegal activity; (5) violence of use of firearms in cannabis growth and distribution; (6) drugged driving and adverse public health consequences from cannabis use; (7) growth of cannabis on federal lands; and (8) cannabis possession or use on federal property.

On January 4, 2017, the U.S. Attorney General Jeff Sessions rescinded the Cole Memo and restored the “rule of law.” Such rescission essentially shifts federal policy from the hands-off approach adopted under the Obama administration to allowing federal prosecutors across the U.S. to decide individually how to prioritize resources to crack down on pot possession, distribution and cultivation of the drug in states where it is legal. Furthermore, the Trump administration has previously indicated that it will pursue the enforcement of federal cannabis laws.

While we do not believe our current activities involve those enumerated in the Cole Memo, in light of the rescission of the memo by the current Attorney General, federal prosecutors will now have significant discretion on their interpretation of these priorities, and no assurances can be given that federal prosecutors will agree with our position. We therefore cannot provide assurance that our actions are in full compliance with the Cole Memo or any other state or federal laws or regulations. In addition, there is no guarantee that the current administration will not further change its policy regarding the strict enforcement of federal laws or the eight listed priorities. Additionally, any new administration that follows could change this policy and decide to enforce the federal laws even stronger. Any such change in the federal government’s enforcement of current federal laws could cause significant financial damage to us and our shareholders.

Some of our business activities and the business activities of some of our customers, while believed to be compliant with applicable state law, are illegal under federal law because they violate the Federal Controlled Substances Act. If we or our customers are closed by law enforcement authorities, it will materially and adversely affect our business.

As of December 31, 2017, 29 states and the District of Columbia have passed laws allowing some degree of medical use of cannabis, while four of those states and the District of Columbia have also legalized the adult-use of cannabis. However, under United States federal law, and more specifically the Federal Controlled Substances Act, the possession, use, cultivation, marketing and transfer of cannabis is illegal. The federal, and in some cases state, law enforcement authorities have frequently closed down dispensaries and investigated and/or closed physician offices that provide medicinal cannabis recommendations. To the extent that we our customers’ dispensary or factory is closed, it will negatively affect our revenue, and to the extent that it prevents or discourages other similar businesses from entering the cannabis industry, our potential customer base would contract, leading to a material negative affect on our business and operations.

The cannabis industry faces strong opposition.

It is believed by many that large well-funded businesses may have a strong economic opposition to the cannabis industry. We believe that the pharmaceutical industry does not want to cede control of any product that could generate significant revenue. For example, medical cannabis will likely adversely impact the existing market for medicines sold by mainstream pharmaceutical companies that contain active ingredients from cannabis. Furthermore, the medical marijuana industry could face a material threat from the pharmaceutical industry, should marijuana displace other drugs or encroach upon the pharmaceutical industry’s products. The pharmaceutical industry is well funded with a strong and experienced lobby that eclipses the funding of the medical cannabis movement. Any inroads the pharmaceutical industry could make in halting or impeding the cannabis industry could have a detrimental impact on our proposed business.

Additionally, we are substantially dependent on continued market acceptance and proliferation of consumers of cannabis, medical marijuana and recreational marijuana. We believe that as marijuana becomes more accepted the stigma associated with marijuana use will diminish and as a result consumer demand will continue to grow. While we believe that the market and opportunity in the marijuana space continues to grow, we cannot predict the future growth rate and size of the market. Any negative outlook on the marijuana industry will adversely affect our business operations.

We and our customers and clients may have difficulty accessing the service of banks, which may make it difficult for them to operate.

Since the use of cannabis is illegal under federal law, there is a compelling argument that banks cannot accept for deposit funds from businesses involved with cannabis. While the Financial Crimes Enforcement Network (“FinCEN”) has provided guidance to financial institutions on how to provide services to marijuana-related businesses consistent with their Bank Secrecy Act obligations, the decision to open, close, or refuse accounts and/or relationships are made at the discretion of the banking institution. Consequently, businesses involved in the cannabis industry often have trouble finding a bank willing to accept their business. The inability to open bank accounts may make it difficult for us and our clients to operate.

Due to our involvement in the cannabis industry, we may have a difficult time obtaining the various insurances that are desired to operate our business, which may expose us to additional risk and financial liability

Insurance that is otherwise readily available, such as general liability, and directors and officer’s insurance, is more difficult for us to find, and more expensive, because we are service providers to companies in the cannabis industry. There are no guarantees that we will be able to find such insurances in the future, or that the cost will be affordable to us. If we are forced to go without such insurances, it may prevent us from entering into certain business sectors, may inhibit our growth, and may expose us to additional risk and financial liabilities.

Laws and regulations affecting the cannabis industry are constantly changing, which could detrimentally affect our business, and we cannot predict the impact that future regulations may have on us.

Local, state and federal medical cannabis laws and regulations are broad in scope and they are subject to evolving interpretations, which could require our licensees to incur substantial costs associated with compliance or to alter one or more of their sales or marketing practices. For example, the rescission of the Cole Memo by U.S. Attorney General Jeff Sessions on January 4, 2018. In addition, violations of these laws, or allegations of such violations, could disrupt our license business and result in a material adverse effect on our revenues under our license agreements, which would negatively affect our profitability and financial condition.

In addition, it is possible that regulations may be enacted in the future that will be directly applicable to us and our business. We cannot predict the nature of any future laws, regulations, interpretations or applications, nor can we determine what effect additional governmental regulations or administrative policies and procedures, when and if promulgated, could have on our business. These potential effects could include, however, requirements for the revisions to our business model to meet new standards, the recall or discontinuance of certain products, or additional record keeping and reporting requirements. Any or all of these requirements could have a material adverse effect on our business, financial condition, and results of operations.

We may not obtain the required state and local licenses required to conduct our business.

Where applicable, we apply for state and/or licenses that are necessary to conduct our business in compliance with local laws. While we are not required to obtain governmental approval in connection with providing the services we offer or for manufacturing the products we sell, establishing an operating dispensary requires governmental approval, usually at the local and state level. Such approval is obtained through a complex licensing process that is newly adopted by the states in almost all cases, which we monitor on behalf of our clients. If we are not granted necessary licenses by the relevant governing bodies, it could have a material adverse effect on our business, financial condition, and results of operations.

We are subject to complex laws and regulations, including environmental laws and regulations, which can adversely affect the cost, manner and feasibility of doing business .

We are subject to complex laws and regulations, including environmental laws and regulations, which can adversely affect the cost, manner and feasibility of doing business.

The operations and facilities of our facilities will be subject to extensive federal, state and local laws and regulations relating to the growth of cannabis and the manufacture and distribution of products containing cannabis (and/or its psychoactive compound, THC). Such existing laws or regulations regarding cannabis and its psychoactive compound, as currently interpreted or reinterpreted in the future, or future laws or regulations, may adversely affect our businesses and sales. Consequently our revenues would thereby decrease, which may have a material adverse effect on our results of operations.

Ordinary and necessary business deduction other than the cost of goods sold are disallowed by the Internal Revenue Service for Cannabis companies under the Internal Revenue Code (the “IRC”) Section 280E.

IRC Section 280E prohibits our businesses from deducting ordinary and necessary business expenses pertaining to cannabis sale, forcing the Company to contend with higher effective federal tax rates than similar companies in other industries. This onerous tax burden significantly impacts the profitability of the Company and may make the pricing of its products less competitive.

If no additional states allow the medicinal or adult-retail use of cannabis, or if one or more states that currently allow it reverse their position, we may not be able to continue our growth, or the market for our products and services may decline.

As of December 31, 2017, 29 states and the District of Columbia have passed laws allowing some degree of medical use of cannabis, while eight of those states and the District of Columbia have also legalized the adult-use of cannabis. There can be no assurance that number of states that allow the use of medicinal and recreational cannabis will grow, and if it does not, there can be no assurance that the 29 existing states and/or the District of Columbia will not reverse their position and make medicinal and recreational cannabis illegal again. If either of these things happens, then not only will the growth of our business be materially impacted, but we may experience declining revenue as the market for our products and services declines.

We may not be able to effectively control and manage our growth.

Our strategy envisions a period of potentially rapid growth. We currently maintain nominal administrative and personnel capacity due to the startup nature of our business, and our expected growth may impose a significant burden on our future planned administrative and operational resources. The growth of our business may require significant investments of capital and increased demands on our management, workforce and facilities. We will be required to substantially expand our administrative and operational resources and attract, train, manage and retain qualified management and other personnel. Failure to do so or satisfy such increased demands would interrupt or would have a material adverse effect on our business and results of operations.

Our industry is highly competitive and we have less capital and resources than many of our competitors which may give them an advantage in developing and marketing products similar to ours or make our products obsolete

We are involved in a highly competitive industry where we may compete with numerous other companies who offer alternative methods or approaches, who may have far greater resources, more experience, and personnel perhaps more qualified than we do. Such resources may give our competitors an advantage in developing and marketing products similar to ours or products that make our products obsolete. There can be no assurance that we will be able to successfully compete against these other entities.

The success of our new and existing partnerships, products, and services is uncertain, and large resources may be required to sustain our current business model.

We have committed, and expect to continue to commit, significant resources and capital to develop and market existing partnership, product, and service enhancements as well as new partnerships, products and services. These partnerships, products and services are relatively new and untested, and we cannot assure you that we will achieve market acceptance for these partnerships, products, and services, or other new partnerships, products and services that we may offer in the future. Moreover, these and other new partnerships, products and services may be subject to significant competition with offerings by new and existing competitors in our sector. In addition, new partnerships, products, services and enhancements may pose a variety of technical challenges and require us to attract additional qualified employees. The failure to successfully develop and market these new partnerships, products, services or enhancements could seriously harm our business, financial condition and results of operations.

Our business is dependent upon continued market acceptance by consumers .

We are substantially dependent on continued market acceptance of our products and our licensees’, lessee’s, or tenant’s products by consumers. Although we believe that the use of cannabis in the United States is gaining stronger consumer acceptance, we cannot predict the future growth rate and size of this market.

If we fail to successfully introduce new partnerships or products, we may lose market position.

New partnerships, products, and product improvements, and line extensions will be an important factor in our sales growth. If we fail to identify emerging consumer and technological trends, to maintain and improve the competitiveness of our existing partnerships and products or to successfully introduce new products on a timely basis, we may lose market position. Continued business development, product development, and marketing efforts have all the risks inherent in the development of new partnerships, products, and line extensions, including development delays, the failure of new partnerships, products and line extensions to achieve anticipated levels of market acceptance and the cost of failed product introductions.

We are dependent upon key personnel whose loss may adversely impact our business.

We rely heavily on the expertise, experience and continued services of Matthew Feinstein, our Chief Executive Officer, President, Secretary and Chairman of the Board of Directors. We are also dependent on our Vice-President, Business Development, Theresa Flynt. The loss of either of these individuals, or an inability to attract or retain other key individuals, could materially adversely affect us. We seek to compensate and motivate these individuals, as well as other personnel, through competitive cash and equity compensation, but there can be no assurance that these programs will allow us to retain key personnel or hire new key personnel. As a result, if any member of our key personnel were to leave, we could face substantial difficulty in hiring a qualified successor and could experience a loss in productivity while any such successor obtains the necessary training and experience.

Our services have never been provided on a mass market commercial basis, and we do not know whether they will be accepted by the market.

The market for cannabis products is at a relatively early stage of development and the extent to which its use will be widely adopted is uncertain. If our services are not accepted by the market, our business plans, prospects, results of operations and financial condition will suffer. Moreover, jurisdictions that have not approved the medicinal and/or adult-retail use of cannabis products may decide not to permit the use of such products. The development of a successful market for our proposed operations and our ability to license our intellectual property and implement our business plan may be affected by a number of factors, many of which are beyond our control. If our proposed operations fail to gain sufficient market acceptance, our business plans, prospects, results of operations and financial condition will suffer.

We may be unable to adequately protect or enforce our patents and proprietary rights.

Our continuing success depends, in part, on our ability to protect our intellectual property and maintain the proprietary nature of our technology through a combination of patents, trademarks, licenses and other intellectual property arrangements, without infringing the proprietary rights of third parties. We cannot assure that these patents, trademarks, licenses and other intellectual property arrangements will be held valid if challenged, or that other parties will not claim rights in or ownership of our patent and other proprietary rights. We also cannot assure that our pending patents will be issued. Moreover, patents issued to us or those we license patents from may be circumvented or fail to provide adequate protection.

Litigation brought by third parties claiming infringement of their intellectual property rights or trying to invalidate intellectual property rights owned or used by us may be costly and time consuming.

We may face lawsuits from time to time alleging that our intellectual property infringes on third-party intellectual property, and/or seeking to invalidate or limit our ability to use our intellectual property. If we become involved in litigation, we may incur substantial expense defending these claims and the proceedings may divert the attention of management, even if we prevail. An adverse determination in proceedings of this type could subject us to significant liabilities, allow our competitors to market competitive products without a license from us, prohibit us from marketing our products or require us to seek licenses from third parties that may not be available on commercially reasonable terms, if at all.

Risks Relating to our “Pineapple Park” Development Project

We may not find enough quality tenants to occupy the cultivation complex and even if we do we may not be able to enter into agreements with them on terms favorable to us or at all.

While we believe that there is enough interest from individuals and entities for us to find reputable and successful tenants, we will need to market to these potential persons and companies and enter into arrangements with them to successfully sublease the entire building we have leased in Adelanto, CA. While we mitigate some risk, we will still incur upfront costs that require capital commitments by the Company. The success of our business model is premised on assumptions about occupancy levels and rental rates, and if those assumptions prove to be inaccurate, our cash flows and profitability will be reduced.

Our tenants may not be able to successfully execute their respective business strategies and may not be able to meet their lease obligations or avoid defaults.

We will depend on rental income from tenants for a significant portion of our revenues. Our financial performance would be adversely affected if a significant number of our tenants fail to meet their lease obligations. We expect our tenants to be successful not only in growing marijuana, but also in developing and marketing their products and successfully executing their business strategies. Should they be unable to grow marijuana or to distribute their products, or if their businesses are not profitable, they may not be able to make their scheduled lease payments and default on their obligations.

The Cities of Adelanto’s and Desert Hot Springs’ laws and regulations may change.

While hawse have leased a building whereby cannabis cultivation activities are currently able to be permitted by the City of Adelanto due to the premises location in what the City deems to be the cultivation “green zone”, changes to the City’s applicable laws and regulations or the permitting process may impact our ability to expand the permit to new tenants. Alleged violation of these laws could disrupt our business and result in a material adverse effect on our operations. In addition, we cannot predict the nature of any future laws, regulations, interpretations or applications of laws and regulations. In Desert Hot Springs we have secured land for the purposes of future development for cannabis business activities. The aforementioned potential changes in regulatory framework could negatively affect our ability to properly develop the parcel as we intend.

Damage from catastrophic weather and other natural events and climate change could result in losses to our Company.

Our buildings and land are susceptible to natural disaster type of events that could interrupt and halt our tenant’s ability to grow and cultivate marijuana. They are located in areas that may experience catastrophic weather and other natural events from time to time, including fires, windstorms or hurricanes, earthquakes, flooding or other severe weather. These adverse weather and natural events could cause substantial damages or losses to our properties which could exceed our insurance coverage. In the event of a loss in excess of insured limits, we could lose our capital invested in the affected property, as well as anticipated future revenue from that property. We could also continue to be obligated to repay any obligations related to the property. Any such loss could materially and adversely affect our business and our financial condition and results of operations. In addition, changes in federal and state legislation and regulation on climate change could result in increased capital expenditures to improve the energy efficiency of our existing properties and could also require us to spend more on our new development properties without a corresponding increase in revenue.

Risks Relating to our Acquisition of THC

We could encounter difficulties integrating THC which could result in substantial costs, delays or other operational or financial difficulties.

We may not be able to profitably manage or successfully integrate THC without substantial costs, delays or other operational or financial difficulties.

In addition, our acquisition of THC involves a number of other risks, including:

The inability to successfully integrate and manage the THC business could result in the incurrence of substantial costs to address the problems and issues encountered.

Our plans to expand our product offerings and sales channels might not be successful, and implementation of these plans might divert our operational, managerial and administrative resources, which could impact our competitive position.

Our success and the planned growth and expansion of our business depend on our products and services achieving greater and broader acceptance, resulting in a larger customer base, and on the expansion of our operations into new markets. However, there can be no assurance that customers will purchase our products and/or services, or that we will be able to continually expand our customer base. Additionally, if we are unable to effectively market or expand our product and/or service offerings, we will be unable to grow and expand our business or implement our business strategy.

Our ability to grow our existing brand and develop or identify new growth opportunities depends in part on our ability to appropriately identify, develop and effectively execute strategies and initiatives. Failure to effectively identify, develop and execute strategies and initiatives may lead to increased operating costs without offsetting benefits and could have a material adverse effect on our results of operations. These plans involve various risks discussed elsewhere in these risk factors, including:

In addition, our ability to successfully carry out our plans to expand our product offerings may be affected by, among other things, laws and regulations pertaining to cannabis use, economic and competitive conditions, changes in consumer spending patterns and consumer preferences, and fashion trends. Our expansion plans could be delayed or abandoned, could cost more than anticipated and could divert resources from other areas of our business, any of which could impact our competitive position and reduce our revenue and profitability.

Because we utilize foreign suppliers, we are subject to numerous risks associated with international business that could increase our costs or disrupt the supply of our products, resulting in a negative impact on our business and financial condition.

Our international operations subject us to risks, including:

These and other factors beyond our control could disrupt the supply of our products, influence the ability of our suppliers to export our products cost-effectively or at all, inhibit our suppliers’ ability to procure certain materials and increase our expenses. Any of these factors could harm our business, financial condition and results of operations.

Cost increases in, or shortages of, the materials or labor used to manufacture our products could negatively impact our business and financial condition.

The manufacture of our Safe Display System is labor intensive and utilizes raw materials supplied by third parties. If the cost of labor materially increases, our financial results regarding that segment of our revenue model could be materially adversely affected. Material increases in labor costs and raw material cost in the U.S. could also force us to move all or a portion of our manufacturing overseas, which could adversely affect our brand identity.

Similarly, increases in the prices of raw materials or the prices we pay to the suppliers of the raw materials used in the manufacturing of our proprietary equipment as well as our THC merchandise, and shortages in such materials, could have a material adverse effect on our financial condition and results of operations relating to those segments of our revenue model. For example, the cost of certain related fabrics has historically fluctuated. Such shortages may result in an increase in our manufacturing costs and could result in a material adverse effect on our financial condition and results of operations. We are unable to predict whether we will be able to successfully pass on the added cost of raw materials to our wholesale and retail customers. In addition, increases in the cost of, or shortages in, our raw material inputs could adversely affect our ability to compete.

A disruption in our information technology infrastructure may interrupt our operations.

We depend on information systems to operate the THC website, process transactions, respond to customer inquiries, manage inventory and production, purchase, sell and ship goods on a timely basis and maintain cost-efficient operations. We may experience operational problems with our information systems as a result of system failures, viruses, computer “hackers” or other causes.

Any material disruption or slowdown of our systems could cause information, including data related to customer orders, to be lost or delayed, delays in the delivery of merchandise to our stores and customers or lost sales.

Moreover, we may not be successful in developing or acquiring technology that is competitive and responsive to the needs of our customers and might lack sufficient resources to make the necessary investments in technology to compete with our competitors. Accordingly, if changes in technology cause our information systems to become obsolete, or if our information systems are inadequate to handle our growth, we could lose customers.

A failure in our online retail operations could significantly disrupt our business and lead to reduced sales and reputational damage.

Our online retail operations accounted for a significant portion of THC’s net sales to date and are subject to numerous risks that could have a material adverse effect on our operational results. Risks to online revenue include, but are not limited to, the following:

Our failure to successfully respond to these risks and uncertainties could reduce Internet sales and damage our brand’s reputation.

Failure to protect the integrity and security of our information systems and our customers’ information could materially adversely affect our results of operations, damage our reputation and expose us to litigation.

Our operations, including sales through our e-commerce website through our licensee, involve the collection, storage and transmission of customers’ credit card information and personal identification data, as well as employee information and non-public company data. The costs associated with maintaining the security of such information, including increased investments in technology, the costs of compliance with consumer protection laws, and costs resulting from consumer fraud or a malicious breach of our information systems, could materially adversely affect our results of operations. If the security of the customer data stored on our servers or transmitted by our network is breached, our reputation could be materially adversely affected, which could negatively impact our sales results, and we could be subject to litigation. To date, we have not experienced a significant security breach.

We may be required to recognize impairment charges that could materially affect our results of operations.

We assess our goodwill and other intangible assets, and our other long-lived assets as and when required by accounting principles generally accepted in the United States (“GAAP”) to determine whether they are impaired. If they are impaired, we would record appropriate impairment charges. It is possible that we may be required to record significant impairment charges in the future and, if we do so, our results of operations could be materially adversely affected.

Risks Related to Ownership of Our Common Stock

The OTC Markets Group identified our common stock with a caveat emptor symbol on March 31, 2016 and the United States Securities and Exchange Commission (the “SEC”) suspended the trading of our common stock from April 28, 2016 through May 11, 2016, causing our common stock to trade on the OTC Grey Market. We do not expect to have the caveat emptor removed or to quote on the OTC Markets or uplist to a national exchange until approximately the second quarter of 2018 calendar year through the filing of this Form 10 and there is no guarantee that we will be successful in achieving the foregoing.

Prior to April 28, 2016, our common stock was quoted on the OTCPink Marketplace. On April 28, 2016 the SEC suspended the trading of our common stock due to market activity that raised concerns about the adequacy of publicly-available information regarding the Company. The trading suspension ended on May 11, 2016 but a broker must also file a Form 15c2-11 with FINRA that must be approved before the common stock can be eligible for quotation on the OTCPink Marketplace. As of the date hereof, no broker has filed a Form 15c2-11 and as a result, our common stock trades on the OTC Grey Market.

On March 31, 2016, the OTC Markets Group identified our securities with a caveat emptor symbol due to trading activity that caused our stock price to rise from a low of $10.10 on March 24, 2016 to a high of $42.38 on March 31, 2016.The caveat emptor symbol is intended to inform investors that there may be reason to exercise additional care and perform thorough due diligence in making investment decisions in an issuer.

We anticipate that a broker will file a Form 15c2-11 and that such form will be approved and that the caveat emptor will be removed after we file this Form 10 with the SEC. Although effective after 60 days from filing, should the SEC refuse to clear comments on the Form 10 or the OTC Markets Group refuse to remove the caveat emptor symbol, our common stock may never be able to transition from the OTC Grey Sheets, the trading price of our common stock could suffer, the trading market for our common stock may be less liquid and our stock price may be subject to increased volatility, making it difficult or impossible for you to resell shares of our common stock.

Due to our connection to the cannabis industry, there can be no assurance that our shares of common stock will ever be approved for listing on a national securities exchange.

Currently, shares of our common stock are traded on the OTC Grey Market and are not listed on any national securities exchange, such as the New York Stock Exchange or the NASDAQ Stock Market. Even if the Company desires to have its shares listed on a national securities exchange, the fact that our business is associated with the use of cannabis, the legal status of which is uncertain in some states and at the federal level, may make any efforts to become listed on a securities exchange more problematic as we believe national exchanges may be reluctant to list shares of companies whose business is associated with the recreational use of cannabis. While we plan to work with NASDAQ or other exchanges in an attempt to change their views of responsible cannabis related businesses, there can be no assurance that our common stock will ever be listed on NASDAQ or any other national securities exchange. As a result, our common stock may never develop an active trading market which may limit our investors’ ability to liquidate their investments or cause our stock price to be particularly volatile.

Our stock may be traded infrequently and in low volumes, so you may be unable to sell your shares at or near the quoted bid prices if you need to sell your shares.

Until our common stock is listed on a national securities exchange, we may only be able to trade our common stock on one of the OTC Markets (if we are successful in applying to trade on such marketplaces) or on the OTC Grey Market. In those venues, however, the shares of our common stock may trade infrequently and in low volumes, meaning that the number of persons interested in purchasing our common stock at or near bid prices at any given time may be relatively small or non-existent. An investor may find it difficult to obtain accurate quotations as to the market value of our common stock or to sell his or her shares at or near bid prices or at all. In addition, if we fail to meet the criteria set forth in SEC regulations, various requirements would be imposed by law on broker-dealers who sell our securities to persons other than established customers and accredited investors. Consequently, such regulations may deter broker-dealers from recommending or selling our common stock, which may further affect the liquidity of our common stock. This would also make it more difficult for us to raise capital.

There currently is no active public market for our common stock and there can be no assurance that an active public market will ever develop. Failure to develop or maintain a trading market could negatively affect the value of our common stock and make it difficult or impossible for you to sell your shares.

There is currently no active public market for shares of our common stock and one may never develop. Our common stock is currently traded on the OTC Grey Market. The OTC Grey Market is a thinly traded market and lacks the liquidity of certain other public markets with which some investors may have more experience. We may not ever be able to satisfy the requirements to be quoted on the OTC Markets or satisfy the listing requirements to be listed on a national securities exchange, which are often more widely-traded and liquid markets. Some, but not all, of the factors which may delay or prevent the quotation or listing of our common stock on a more widely-traded and liquid market include the following: our stockholders’ equity may be insufficient; the market value of our outstanding securities may be too low; our net income from operations may be too low; our common stock may not be sufficiently widely held; we may not be able to secure market makers for our common stock; and we may fail to meet the rules and requirements mandated by the several exchanges and markets to have our common stock listed. Should we fail to satisfy the initial listing standards of the national exchanges or OTC Markets, or our common stock is otherwise rejected for listing or quotation, and remains traded on the OTC Grey Market, the trading price of our common stock could suffer and the trading market for our common stock may be less liquid and our common stock price may be subject to increased volatility, making it difficult or impossible to sell shares of our common stock.

We do not intend to pay dividends in the foreseeable future.

We do not intend to pay any cash dividends in the foreseeable future. We do not plan on making any cash distributions in the manner of a dividend or otherwise. Our Board presently intends to follow a policy of retaining earnings, if any.

Investors may experience dilution of their ownership interests because of the future issuance of additional shares of our common or preferred stock or other securities that are convertible into or exercisable for our common or preferred stock.

In the future, we may issue our authorized but previously unissued equity securities, resulting in the dilution of the ownership interests of our present stockholders. We are authorized to issue an aggregate of 500,000,000 shares of common stock and 20,000,000 shares of “blank check” preferred stock. We may issue additional shares of our common stock or other securities that are convertible into or exercisable for our common stock in connection with hiring or retaining employees, future acquisitions, future sales of our securities for capital raising purposes, or for other business purposes. The future issuance of any such additional shares of our common stock may create downward pressure on the trading price of the common stock. We will need to raise additional capital in the near future to meet our working capital needs, and there can be no assurance that we will not be required to issue additional shares, warrants or other convertible securities in the future in conjunction with these capital raising efforts, including at a price (or exercise or conversion prices) below the price an investor paid for stock.

Being a public company is expensive and administratively burdensome.

As a company whose common stock is quoted on the OTC marketplace, we are subject to federal securities laws, rules and regulations related thereto. Complying with these laws and regulations requires the time and attention of our Board of Directors and management, and increases our expenses. After we file this Form 10 with the SEC we will become fully subject to the information and reporting requirements of the Securities Act, the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and other federal securities laws, rules and regulations related thereto, including compliance with the Sarbanes-Oxley Act. Complying with these laws and regulations requires the time and attention of our Board of Directors and management, and increases our expenses. We estimate that we will incur approximately $150,000 to $200,000 in 2017 to comply with public company compliance requirements with many of those costs recurring annually thereafter.

Among other things, we will be required to:

The costs of preparing and filing annual and quarterly reports, proxy statements and other information with the SEC and furnishing audited reports to stockholders are expensive and much greater than that of a privately-held company, and compliance with these rules and regulations may require us to hire additional financial reporting, internal controls and other finance personnel, and will involve a material increase in regulatory, legal and accounting expenses and the attention of management. There can be no assurance that we will be able to comply with the applicable regulations in a timely manner, if at all. In addition, being a public company makes it more expensive for us to obtain director and officer liability insurance. In the future, we may be required to accept reduced coverage or incur substantially higher costs to obtain this coverage.

Our common stock is subject to the “penny stock” rules of the SEC and the trading market in the securities is limited, which makes transactions in the stock cumbersome and may reduce the value of an investment in the stock.

Rule 15g-9 under the Exchange Act establishes the definition of a “penny stock,” for the purposes relevant to us, as any equity security that has a market price of less than $5.00 per share or with an exercise price of less than $5.00 per share, subject to certain exceptions. For any transaction involving a penny stock, unless exempt, the rules require: (a) that a broker or dealer approve a person’s account for transactions in penny stocks; and (b) the broker or dealer receive from the investor a written agreement to the transaction, setting forth the identity and quantity of the penny stock to be purchased.

In order to approve a person’s account for transactions in penny stocks, the broker or dealer must: (a) obtain financial information and investment experience objectives of the person and (b) make a reasonable determination that the transactions in penny stocks are suitable for that person and the person has sufficient knowledge and experience in financial matters to be capable of evaluating the risks of transactions in penny stocks.

The broker or dealer must also deliver, prior to any transaction in a penny stock, a disclosure schedule prescribed by the SEC relating to the penny stock market, which, in highlight form: (a) sets forth the basis on which the broker or dealer made the suitability determination; and (b) confirms that the broker or dealer received a signed, written agreement from the investor prior to the transaction. Generally, brokers may be less willing to execute transactions in securities subject to the “penny stock” rules. This may make it more difficult for investors to dispose of our common stock and cause a decline in the market value of our common stock.

Disclosure also has to be made about the risks of investing in penny stocks in both public offerings and in secondary trading and about the commissions payable to both the broker or dealer and the registered representative, current quotations for the securities and the rights and remedies available to an investor in cases of fraud in penny stock transactions. Finally, monthly statements have to be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny stocks.

Offers or availability for sale of a substantial number of shares of our common stock may cause the price of our common stock to decline.

If our stockholders sell substantial amounts of our common stock in the public market, including upon the expiration of any lockup periods or the statutory holding period under Rule 144, or issued upon the conversion of preferred stock, it could create a circumstance commonly referred to as an “overhang” and in anticipation of which the market price of our common stock could fall. The existence of an overhang, whether or not sales have occurred or are occurring, also could make more difficult our ability to raise additional financing through the sale of equity or equity-related securities in the future at a time and price that we deem reasonable or appropriate.

An investment in our securities is speculative and there can be no assurance of any return on any such investment.

An investment in our securities is speculative and there is no assurance that investors will obtain any return on their investment. Investors will be subject to substantial risks involved in an investment in our Company, including the risk of losing their entire investment.

Item 2. Financial Information.

The discussion of our financial condition and operating results should be read together with our accompanying audited consolidated financial statements included in this Registration Statement.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward Looking Statements

You should read the following discussion of our financial condition and results of operations together with our audited consolidated financial statements and interim unaudited condensed consolidated financial statements and notes to such financial statements included elsewhere in this Form 10. The following discussion contains forward-looking statements that involve risks and uncertainties. The forward-looking statements are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry, business and future financial results. Our actual results could differ materially from the results contemplated by these forward-looking statements due to a number of factors, including those discussed under “Item 1A. Risk Factors” and other sections in this Form 10.

Overview

We were originally formed in the state of Nevada under the name Global Resources, Ltd. on August 3, 1983. We changed our name to “Helixphere Technologies Inc.” on April 12, 1999 and to “New China Global Inc.” on October 2, 2013. We reincorporated in Wyoming on October 30, 2013 and changed our name to Globestar Industries on July 15, 2014. On August 24, 2015, we entered into a share exchange agreement with Better Business Consultants, Inc. (“BBC”) (dba “MJ Business Consultants”), a corporation formed in state of California on January 29, 2015, all of BBC’s shareholders, and our majority shareholder (the “ Share Exchange ”). Upon the consummation of the Share Exchange, BBC became a wholly owned subsidiary of our Company, we ceased our prior business of providing educational services and continued the business of BBC as our sole line of business. On September 3, 2015, we changed our name to “Pineapple Express, Inc.” BBC currently has two wholly owned subsidiaries, Pineapple Express One LLC, a California limited liability company, and Pineapple Express Two LLC, a California limited liability company.

On February 12, 2016, we entered into an Agreement of Merger to acquire all of the assets and, except for those undisclosed liabilities specified in the Agreement of Merger, assume all the liabilities of THC Industries, Inc., a California corporation (“THC Parent”), through a two-step merger by and among our Company, THC Parent, our wholly owned subsidiary THC Industries, LLC, a California limited liability company (“THC”), and our former wholly owned subsidiary THC Merger Co., Inc., a California corporation (the “THC Merger”). The transaction was delayed and on June 22, 2017, we successfully completed the conditions of a Standstill and Waiver Agreement signed between the parties on March 27, 2017, which resulted in a transfer and ownership of the assets relative to the purchase transaction. As a result of the THC Merger, THC became our wholly owned subsidiary.

On March 14, 2017, we entered into a Share Purchase Agreement (the “Share Purchase Agreement”) to sell BBC and its two wholly owned subsidiaries, Pineapple Express One LLC and Pineapple Express Two LLC to, Jaime Ortega, our largest shareholder and a related party, so that he can fund and prosecute litigation claims and settle debts for such subsidiaries, resulting from unconsummated parcel purchases we feel was purposely circumvented by 3 ^rd parties involved in those transactions. Mr. Ortega took these steps so our claims can be addressed against the parties at fault without negatively impacting or distracting us.

On March 16, 2017, we formed Pineapple Express Consulting, Inc. (“PEC”) as a wholly owned subsidiary. Yucca Road Lease, LLC (“YRL”), a California limited liability company, formed by Sky Island, the owner of whom is our largest shareholder, on June 27, 2017 for the purpose of leasing or acquiring properties in the Yucca Road area of Adelanto, CA for purposes of advancing the business objective of our Company. On July 12, 2017, Sky Island changed the name of YRL to Pineapple Park, LLC (“PP”). On August 3, 2017, PP was conveyed to us by Sky Island for $100,000 an amount Sky Island had already paid as a deposit to Adelanto Property Management, LLC against a “master lease” for the Yucca Road premises at 10007-10019 Yucca Road, Adelanto, CA 92301. This $100,000 deposit was added to the debt owed by us to Sky Island, in essence, acquiring PP for no consideration. During the course of PP’s ownership by Sky Island, Sky Island also formed Pineapple Ventures Inc. (“PVI”), which entity applied for a permit from the City of Adelanto for commercial cannabis cultivation and manufacturing activities at the leased site. Once, and if, this application is approved, we have an option to purchase PVI from Sky Island for $1,000,000. As of the date of this filing, the applied for permit has not been granted nor has management indicated its intention to exercise the purchase option.

Through our operating subsidiary PEC, we provide capital to our canna-business clientele and provide consulting services and technology to develop, enhance, and expand existing and newly formed canna-businesses. Through PP, we develop, lease, and manage real estate properties for the use of PEC canna-business clients of PEC. Through our operating subsidiary THC, we operate a branded clothing line and own the rights to sell apparel such as t-shirts, hats, beanies, pants, shorts, baseball jerseys, jackets, sweatshirts, polo shirts, sweat pants and other attire displaying the THC trademarked name and logo, operate a clothing distribution facility and own the rights to the THC.com URL address.

We also intend to create a nationally branded and vertically integrated chain of cannabis retail stores under the “Pineapple Express” brand, which will be supported by anticipated Company-owned cultivation and processing facilities, and will feature products from anticipated Company-owned manufacturers. Our goal is that within five years the chain will consist of five Company-owned and operated facilities, and 20 licensee-owned cannabis retail stores. Currently our operations are limited to investing in existing and new canna-businesses, leasing real property to canna-businesses, consulting, product licensing, leasing and selling industry specific technology, and providing ancillary support services. However, we are currently in the process of transitioning to operating our own city and state licensed cannabis production, manufacturing, and distribution facility in Adelanto, CA within the next 6 months. However, the recent shift in Federal enforcement relative to the cannabis industry may delay or alter these plans until the Federal position is more certain.

Companies in the cannabis industry face unique challenges and risks. To mitigate these risks, we operate both as an operating business and as a business that invests in other entities. It is our intention that this strategy will enable us to quickly develop recurring and easily replicable revenue sources, and avoid large upfront investments in infrastructure, escalating payroll costs associated with expansion, and the years of initial losses often typical of start-up companies. We believe that our competitive advantages include our business model, our exclusive proprietary technology, our employees’ and consultants’ extensive experience, and our key industry contacts in an industry that is both new and foreign to most. It is our expectation that these factors will set us apart from most of our competitors.

The existing operations are limited to investing in existing or new canna-businesses, leasing real property to canna-businesses, product licensing, and providing ancillary support services. We also intend to create a nationally branded and vertically integrated chain of cannabis retail stores under the “Pineapple Express” brand, which will be supported by future financings or anticipated Company-owned cultivation and processing facilities, and will feature products from anticipated Company-owned manufacturers.

We believe that due to the highly-fragmented nature of the existing cannabis industry, a vertically integrated supply chain will provide a sustainable competitive advantage over competitors, allow faster growth, more consistent product offerings, and make Pineapple Express more attractive for prospective licensees.

Results of Operations

For the Nine Month Period Ended September 30, 2017, as Compared to the Comparable Prior Period Ended September 30, 2016

Revenues and Cost of Goods Sold . We had $606,576 in revenues for the nine month period ended September 30, 2017 consisting of $250,000 in consulting services, including $55,000 for Project Dreams, LLC and $195,000 for Verde Industries; $18,750 License Fee on a $150,000 one-time license fee for THC URL commercial rights pro-rated over a sixty month period on a licensing agreement executed on May 26, 2017; and $337,826 in rent income for Project Dreams, LLC, Herbal Healing Center and Verde Industries, LLC commencing August 1, 2017 at a monthly rate of $57,500/month each, discounted to reflect a three month rent abatement period on each. No revenue was recorded in the comparable prior period ended September 30, 2016. No cost of goods sold were recorded during either period in 2017 or 2016.

General and Administrative . General and administrative expenses for the nine month period ended September 30, 2017 were $882,586, a significant decrease of $2,249,753, or 72%, from $3,132,339 incurred comparable prior period ended September 30, 2016. The decrease was the result of the sale of Company subsidiaries Better Business Consultants, Inc. and Pineapple Express 2, LLC and the abandonment of the DHS project during the period after September 30, 2016 that necessitated lower staffing levels, professional and service provider costs, and associated operating costs involved with multi-company operations. During the nine month period ended September 30, 2017 stock based compensation with an imputed value of $142,000, was recorded all for employment services.

Depreciation/Impairment. Depreciation expense for the nine month period ended September 30, 2017 was $6,472. Depreciation represented an increase of $2,159 from $4,313 incurred for the comparable prior period. No impairment charges were recorded in the nine month period ended September 30, 2017, however, $2,785,340 were incurred in the comparable prior period in 2016 as a consequence of the impairment of all assets acquired in the THC transaction. The increase in depreciation expenses represented a normal depreciation of existing assets. Assets acquired during the period ended September 30, 2017 included a non-depreciable land asset with a purchase value of $700,000 on April 5, 2017 and Leasehold Improvements of $76,600 on the Adelanto, CA leased facility that were not depreciated during that period.

Other income/expense. The Company had no “Other income” for the nine months ended September 30, 2017 and “Other expense” of $273,566, consisting of $256,732 in interest expense, $7,870 in changes to derivatives, and $8,964 for loss on settlement of debt. During the comparable prior period ended September 30, 2016, the Company had $2,647,248 of “Other expenses”, including $158,544 in interest expense, $2,785,340 in impairment losses, off-set by gains of $251,102 in the change in fair value of derivative liability and $45,534 gain on the disposition of a building.

Gain in fair value of change in put agreement. In connection with the THC Merger, we issued shares of our common stock which were required to repurchase 24 to 30 months subsequent from the closing date of the THC Merger dependent on the market price of our common stock. As such, we were required to record the put agreement at market at the date of obligation and to mark to market each reporting period. Our initial valuation of the put options as of the date of acquisition on February 12, 2016 was $706,616, on September 30, 2016 was $455,514, and as of FYE December 31, 2016 we recorded fair value of our put options at $513,868 and recorded a gain of $192,748. As of September 30, 2017, the put options were valued at $521,738 and recorded a loss of $7,870.

Interest expense . Interest expense accrued for the nine month period ended September 30, 2017 was $256,732 compared with $158,544 in the comparable prior period in 2016. Interest expense in both periods occurred because of: (i) the of the promissory notes to Ramsey Salem, and subsequent payoff in FYE 2017, (ii) restructuring the Sky Island promissory notes, and (iii) payment or reduction of various notes payable associated with the Desert Hot Springs project (the “DHS Project”). Imputed interest of $34,812 was charged against additional paid in capital on notes originally recorded without interest and a penalty portion of a deferred liability during the nine month period ended September 30, 2017.

Net loss. Net loss for the nine month period ended September 30, 2017 was $556,048 compared to a net loss of $5,783,900 for the comparable period in 2016.

For the Three Month Period Ended September 30, 2017, as Compared to the Comparable Prior Period Ended September 30, 2016

Revenues and Cost of Goods Sold . We had $602,826 in revenues for the three month period ended September 30, 2017 consisting of completed consulting projects, including $55,000 for Project Dreams, LLC, $295,000 for Verde Industries, LLC, $15,000 from licensing fees, and $337,826 in rent income compared to no revenue in the comparable prior period ended September 30, 2016. No cost of goods sold were recorded during either period in 2017 or 2016.

General and Administrative . General and administrative expenses for the three month period ended September 30, 2017 were $290,087, a significant decrease of 1,574,705, or 84%, from $1,864,792 incurred comparable prior period ended September 30, 2016. The decrease was the result of the sale of Company subsidiaries Better Business Consultants, Inc. and Pineapple Express 2, LLC and the abandonment of the DHS project during the period after September 30, 2016 that necessitated lower staffing levels, professional and service provider costs, and associated operating costs involved with multi-company operations. During the three month period ended September 30, 2017 stock based compensation with a value of $142,000 and, in addition, an imputed value of $31,875 for accrued shares due Company executives in the three month period, all for employment services.

Depreciation/Impairment. Depreciation expense for the three month period ended September 30, 2017 was $2,158, compared to $2,340 incurred for the comparable prior period. No impairment charges were recorded in the three month period ended September 30, 2016 and 2017. The increase in depreciation expenses represented a normal depreciation of existing assets as no new depreciable assets were acquired in the three month period ended September 30, 2017.

Other income/expense. The Company had interest expense of $50,809 and a gain on change in fair value of derivative liability valuation of $23,255 and a loss on settlement of debt of $10,000 representing a total other expenses of $37,554 for the three month period ended September 30, 2017 compared to interest income of $102,706, loss in change in fair value of derivatives liability of $15,088, other expenses of $26,552, Impairment loss of $2,785,370 and a gain on the disposition of a building of $45,534 for an aggregate total other expenses of $2,678,740 for the comparable prior three month period ended 2016.

Gain in fair value of change in put agreement. In connection with the THC Merger, we issued shares of our common stock which were required to repurchase 24 to 30 months subsequent from the closing date of the THC Merger dependent on the market price of our common stock. As such, we were required to record the put agreement at market at the date of obligation and to mark to market each reporting period. Our initial valuation of the put options as of the date of acquisition on February 12, 2016 was $706,616 and as of FYE December 31, 2016 we recorded fair value of our put options at $513,868 and recorded a gain of $192,748. For the three month period from July 1, 2017 through September 30, 2017, the put options were valued at $521,738 with a recorded loss of $23,255.

Interest expense . Interest income for the three month period ended September 30, 2016 was $102,706 compared to an expense of $50,809 for the three month period ended September 30, 2017. Imputed interest was $11,604 and $14,895 for the three month periods ended September 30, 2017 and 2016 respectively

Net loss. Net income for the three month period ended September 30, 2017 was $273,027 compared to a net loss of $4,529,833 in the comparable prior three month period in 2016.

For the Fiscal Year Ended December 31, 2016, as Compared to the Fiscal Year Ended December 31, 2015

Revenues and Cost of Goods Sold . We had no revenues or cost of goods sold during the fiscal years ended December 31, 2016 and 2015.

General and Administrative . General and administrative expenses for the fiscal year ended December 31, 2016 were $3,476,276, an increase of 2,321,671, or 202%, from $1,154,605 incurred for the year ended December 31, 2015. As we were beginning operations in January 2015, the significant increases were primarily due to added staffing levels, professional and service provider costs and establishing facilities. During the fiscal year period ended December 31, 2016, stock based compensation was $1,528,615, including $1,506,615 for services and $22,000 for equipment purchases as compared to $86,839 in 2015.

Depreciation/Impairment. Depreciation expense for the fiscal year ended December 31, 2016 was $6,662 and impairment was $2,785,339. Depreciation represented an increase of $5,515 from $1,147 incurred for the comparable prior period. No impairment charges were recorded in the fiscal year ended December 31, 2015. The increase in depreciation expenses is the result of added office and support equipment. Impairment on the intangible assets was a result our management’s valuation as verified by a Black Scholes assessment of our put option as part of the THC acquisition.

Other income/expense. Other income for the fiscal year ended December 31, 2016 was $6,990 compared to other expense of $32,356 for the fiscal year ended December 31, 2015. During the fiscal year ended December 31, 2016, $280,475 was recorded as interest expenses, $2,785,339 as impairment losses, $2,020,414 was recognized as a loss on dispositions resulting from the liquidation of investments and acquisitions related to the DHS project, $192,748 as a gain on the THC put options, and $227,540 write offs as a result of abandonment of investments against the DHS project..

Gain in fair value of change in put agreement. In connection with the THC Merger, we issued shares of our common stock which were required to repurchase 24 to 30 months subsequent from the closing date of the THC Merger dependent on the market price of our common stock. As such, we were required to record the put agreement at market at the date of obligation and to mark to market each reporting period. Our initial valuation of the put options as of the date of acquisition on February 12, 2016 was $706,616 and as of FYE December 31, 2016 we recorded fair value of our put options at $513,868 and recorded a gain of $192,748.

Interest expense . Interest expense accrued for the fiscal year ended December 31, 2016 was $430,475 related to: (i) promissory notes to Sky Island, (ii) promissory notes to Ramsey Salem issued as consideration for the acquisition of THC, and (iii) various notes payable associated with the Desert Hot Springs project (the “DHS Project”). Imputed interest of $44,684 was charged against additional paid in capital on notes originally recorded without interest and a penalty portion of a deferred liability. No interest expense was recorded for the fiscal year ended December 31, 2015.

Net loss. Net loss for the fiscal year ended December 31, 2016 was $8,596,968, as compared to a net loss of $1,188,108 for the fiscal year ended December 31, 2015.

Liquidity and Capital Resources

As of September 30, 2017, we had a working capital deficit of $4,399,437. Working capital as of September 30, 2017 was comprised of cash of $240, accounts receivable of $50,000, $7,771 in prepaid expenses, and $162,146 in deferred rental income. In the nine month period ended September 30, 2017, we received $141,900 in cash from financing activities, including $645,000 in proceeds from the sale of our common stock and $65,892 from the issuance of promissory notes to related parties, offset by repayment of promissory notes payable for $510,192 and $58,800 payment to advance on agreement. For the fiscal year period ended December 31, 2016, we received $2,163,093 in cash from financing activities, including $2,016,000 in proceeds from the sale of our common stock, $746,066 from the issuance of notes payable, of which $641,000 was from related parties; offset by repayment of notes payable and capital leases for $550,000. For the nine months ended September 30, 2017, we incurred operating expenses of $889,058, including $882,586 in general and administrative expenses and $6,472 in depreciation expenses. For the fiscal year ended December 31, 2016, we incurred operating expenses of $3,482,938 including $3,476,276 in General and Administrative Expenses and $6,662 in depreciation expenses.

We have funded our operations since inception primarily through the issuance of equity in private placements to third parties and/or promissory notes to related parties for cash. The cash was used primarily for operating activities, including cost of employees, management services, professional fees, consultants and travel. Our management expects that cash from operating activities will not provide sufficient cash to fund normal operations, support debt service, or undertake certain investments we anticipate to prosecute our business proposition both in the near and intermediate terms. We will continue to rely on financing provided under notes from related and 3 ^rd party sources, as well as sale of shares of our common stock in private placements, to fund our expected cash requirements.

As of September 30, 2017, we had current liabilities of $4,619,594, comprised of $1,345,896 in accounts payable, $131,934 in accrued interest payable, note payable due to related parties of $1,215,892, notes payable of $47,069, advances on agreements (short term) of $608,161, deferred revenue of $576,250, security deposit on a lease agreement of $170,680, deferred rent income of $1,974, and derivative liabilities of $521,738 related to the Black Scholes treatment of our put options. This compares with current liabilities of $3,849,491, comprised of $1,511,962 in accounts payable, $88,321 in accrued interest payable, note payable due to related parties of $733,000, notes payable of $557,261, advances on agreements (short term) of $445,079, and derivative liabilities of $513,868 related to the Black Scholes treatment of our put options

We intend to raise additional capital through private placements of debt and/or equity securities, but there can be no assurance that these funds will be available on terms acceptable to us, if at all, or will be sufficient to enable us to fully complete our development activities or sustain operations. If we are unable to raise sufficient additional funds, we will have to develop and implement a plan to further extend payables, reduce overhead, or scale back our current business plan until sufficient additional capital is raised to support further operations. There can be no assurance that such a plan will be successful.

Going Concern

Our consolidated financial statements included elsewhere in this Form 10 have been prepared assuming that we will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business. As reflected in such consolidated financial statements, we had a stockholders’ deficit of $3,639,233 at September 30, 2017, and incurred a net loss of $556,048 and utilized net cash of $94,300 in operating activities for the nine-month period then ended. These factors raise substantial doubt about our ability to continue as a going concern. In addition, our independent registered public accounting firm in their audit report to our financial statements for the fiscal year ended December 31, 2016 expressed substantial doubt about our ability to continue as a going concern. Our ability to continue as a going concern was raised due to our net losses and negative cash flows from operations since inception and our expectation our expectation that these conditions may continue for the foreseeable future. In addition, we will require additional financing to fund future operations. Our consolidated financial statements included elsewhere in this Form 10 do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.

Based on our management's estimates and expectation to continue to receive short-term debt funding from a related party on as needed basis, we believe that current funds on hand and proceeds of such loans will be sufficient for us to continue operations through December 31, 2018. Our ability to continue as a going concern is dependent on our ability to execute our business strategy and in our ability to raise additional funds. Management is currently seeking additional funds, primarily through the issuance of equity and/or debt securities for cash to operate our business, however, we can give no assurance that any future financing will be available or, if at all, and if available, that it will be on terms that are satisfactory to us. Even if we can obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing, or cause substantial dilution for our stockholders, in case of equity and/or convertible debt financing.

Off-Balance Sheet Arrangements

As of August 3, 2017 we have entered into an agreement with Sky Island wherein certain assets were acquired consisting of a “master lease” for the 10007 Yucca Road, Adelanto, CA project, recorded on our books and records as an increase in our related party notes payable to Sky Island. As an integral part of the agreement, we also committed to purchase Sky Island’s subsidiary, Pineapple Ventures Inc. (“PVI”) for $1,000,000 once, and if, the PVI application to the City of Adelanto has been approved for commercial cannabis cultivation and manufacturing for the Yucca Road site. The transaction represents a contingent liability and has not been recorded on our books and records of the Company at the time of the filing of this Form 10.

Critical Accounting Policies

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the recoverability and useful lives of long-lived assets, the fair value of our stock, stock-based compensation and the valuation allowance related to deferred tax assets. Actual results may differ from these estimates.

Revenue Recognition

Lease/Leasehold Improvement/Construction

The Company will recognize revenue from rent, tenant reimbursements, and other revenue sources once all of the following criteria are met in accordance with Accounting Standards Codification (“ASC”) subtopic 605 – Revenue Recognition: (a) the agreement has been fully executed and delivered; (b) services have been rendered: (c) the amount is fixed and determinable; and (d) the collectability of the amount is reasonably assured.

In accordance with ASC 840 – Leases, minimum rental revenue will be recognized in rental revenues on a straight-line basis over the term of the related lease. Rental revenue recognition commences when the tenant takes possession or controls the physical use of the leased space. In order for the tenant to take possession, the leased space must be substantially ready for its intended use. To determine whether the leased space is substantially ready for its intended use, management evaluates whether the Company or tenant is the owner of the tenant improvements for accounting purposes. When management concludes that the Company is the owner of the tenant improvements, rental revenue recognition begins when the tenant takes possession of the finished space, which is when such tenant improvements are substantially complete. In certain instances, when management concludes that the Company is not the owner (the tenant is the owner) of tenant improvements, rental revenue recognition begins when the tenant takes possession of or controls the space.

When management concludes that the Company is the owner of tenant improvements, for accounting purposes, management records the cost to construct the tenant improvements as a capital asset. In addition, management records the cost of certain tenant improvements paid for or reimbursed by tenants as capital assets when management concludes that the Company is the owner of such tenant improvements. For these tenant improvements, management records the amount funded or reimbursed by tenants as deferred revenue, which is amortized as additional rental income over the term of the related lease. When management concludes that the tenant is the owner of the tenant improvements for accounting purposes, management records the Company’s contribution towards those improvements as a lease incentive, which is amortized as reduction to rental revenue on a straight-line basis over the term of the lease.

Deferred Leasing Costs

We consider a number of different factors to evaluate whether we or the lessee is the owner of the tenant improvements for accounting purposes. These factors include: (i) whether the lease stipulates how and on what a tenant improvement allowance may be spent; (ii) whether the tenant or landlord retains legal title to the improvements; (iii) the uniqueness of the improvements; (iv) the expected economic life of the tenant improvements relative to the term of the lease; and (v) who constructs or directs the construction of the improvements. The determination of who owns the tenant improvements for accounting purposes is subject to significant judgment. In making that determination, we consider all of the above factors. No one factor, however, necessarily establishes any determination.

Direct leasing costs, primarily consisting of third-party leasing commissions, tenant inducements and legal costs are capitalized and amortized over the life of the related lease. Tenant inducement amortization is recorded as an offset to rental revenue and the amortization of other direct leasing costs is recorded in amortization expense.

Tenant inducement amortization was $165,313 for the five month period December 31, 2017. For the years ended December 31, 2018 through 2021, $148,063, $130,813, $113,563, and $96,313 respectively until the total inducement amortizes in July, 2027.

As Lessee

We have leased properties that are subject to long-term leases and we lease office space, parking space, and equipment. Total rent expense for the year ended December 31, 2017 was approximately $376,250. These expenses only cover lease spaces of 50,000 sq. ft.in Phase 1 of the development. Of Phase 1, PNPL has sub-leased 34,133 sq. ft., leaving a remainder of 15,867 sq. ft. in Phase 1 and out of a total of 107,262 sq. ft., 73,129 sq. ft. remain for development.

Future minimum base rental payments payable by us under our non-cancelable “master lease” are as follows:

As addition sub-leases are executed in following period, these balances will increase.

Revenue Recognition and Valuation of Receivables

We are required to recognize minimum rent revenues on a straight-line basis over the terms of tenant leases, including rent holidays and bargain renewal options, if any. Revenues associated with tenant reimbursements are recognized in the period in which the expenses are incurred based upon the tenant’s lease provision. Leases are not uniform in dealing with such cost reimbursements and there are many variations to the computation. We make quarterly accrual adjustments, positive or negative, to tenant reimbursement revenue to adjust the recorded amounts to our best estimate of the final amounts to be billed and collected with respect to the cost reimbursements. Revenues relating to lease termination fees are recognized on a straight line basis amortized from the time that a tenant’s right to occupy the leased space is modified through the end of the revised lease term and are included in other revenue in the accompanying consolidated statements of operations. To the extent our leases provide for rental increases at specified intervals, we will record a receivable for rent not yet due under the lease terms. Accordingly, our management must determine, in its judgment, to what extent the unbilled rent receivable applicable to each specific tenant is collectible. We review unbilled rent receivables on a quarterly basis and take into consideration the tenant’s payment history, the financial condition of the tenant, business conditions in the industry in which the tenant operates and economic conditions in the area in which the property is located. In the event that the collectability of unbilled rent with respect to any given tenant is in doubt, we would be required to record an increase in our allowance for doubtful accounts or record a direct write-off of the specific rent receivable.

License Fees

Fees received in exchange for a license or other intangible right or for the performance of certain tasks related to a future service, the Company deems does not result in revenue recognition upon delivery. A license provided does not constitute deliverables that a customer would pay for, absent an ongoing service arrangement. In the case of PNPL, a licensing fee for the delivery of a future service will be recognized over the term of the license. Absent a term in the licensing agreement, for an intangible right related to our intellectual property or URL rights, the Company shall deem a term of five (5) years.

Investments

We have adopted Accounting Standards Codification subtopic 323-10, Investments-Other (“ASC 325-10) which requires the accounting for investments at the lower of cost or fair value where the Company cannot exert significant influence of a joint venture or equity investment. We account for our 15.18% ownership of Nature’s Treatment of the Quad Cities, LLC, NTQC Series II (“Series II”) utilizing the cost method of accounting.

Stock-Based Compensation

We measure the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees and directors, the fair value of the award is measured on the grant date and for non-employees, the fair value of the award is generally re-measured on vesting dates and interim financial reporting dates until the service period is complete. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Stock-based compensation expense is recorded by us in the same expense classifications in the consolidated statements of operations, as if such amounts were paid in cash.

Leases

We currently lease properties in locations that would be acceptable for regulatory purposes and acceptable to sub-lessees for the manufacturing and development of their products. We evaluate the lease to determine its appropriate classification as an operating or capital lease for financial reporting purposes. We currently have one lease which is not classified as a capital lease.

Minimum base rent for our operating leases, which generally have escalating monthly rents over the term of the lease, is recorded on a straight-line basis over the lease term. The initial rent term include may include a build-out, or may include a short holiday period, where no rent payments are typically due under the terms of the lease.

Item 3. Properties.

On June 1 ^st , 2016, we moved into our current office space located at 10351 Santa Monica Blvd., Suite 420, Los Angeles, CA. The space has 2,149 rentable square feet and a lease term of four years. We currently pay a total of $8,079 per month for the location. We believe that such property is in good condition and is suitable for the conduct of our business.

On April 5, 2017, we entered into a real estate purchase transaction for a 1.26-acre parcel of land in Desert Hot Springs, CA that we intend to develop over the course of the next 24 months. The parcel purchase was finalized on July 24, 2017 for $700,000 and we took possession of the parcel. In order to finance this purchase, we borrowed $700,000 from a related party entity, Sky Island, Inc., controlled by our largest shareholder, Jaime Ortega.

Through PP, we have leased 107,000 square feet of permitted commercial cultivation warehouse space in Adelanto, CA so it can sublease the same at a profit to its clients and tenants in Southern California. We have subleased approximately 34,000 square feet and plans to lease its remaining 73,000 square feet to new and existing clientele.

Item 4. Security Ownership of Certain Beneficial Owners and Management.

The following table sets forth certain information, as of December 31, 2017, with respect to the beneficial ownership of the Company’s outstanding common stock by (i) any holder of more than 5%; (ii) each of the Company’s executive officers and directors; and (iii) the Company’s directors and executive officers as a group. Unless otherwise indicated, the persons named in the table below have sole voting and investment power with respect to the number of shares indicated as beneficially owned by them.

Our directors are appointed for a one-year term to hold office until the next annual general meeting of our shareholders or until removed from office in accordance with our bylaws. Our officers are appointed by our board of directors and hold office until removed by the board. All officers and directors listed above will remain in office until the next annual meeting of our stockholders, and until their successors have been duly elected and qualified. There are no agreements with respect to the election of Directors. Our Board of Directors appoints officers annually and each executive officer serves at the discretion of our Board of Directors.

Matthew Feinstein. Mr. Feinstein, a founder of the Company, was appointed our Chief Executive Officer, President, Secretary, Chairman of the Board, and Interim Chief Financial Officer on August 24, 2015 upon consummation of the Share Exchange. He has served as the President and a director of BBC since February 13, 2015.Mr. Feinstein has been actively involved in the cannabis industry since 2013.At the Company, Mr. Feinstein is responsible for sourcing investment opportunities, joint venture relationships, and identifying acquisition targets. He is also responsible for developing the Company’s objectives. Prior to forming Better Business Consultants, Inc., which was acquired by the Company on August 24, 2015, Mr. Feinstein was associated with Medbox, Inc. in various capacities as a consultant and employee from June 2013 to December 2014, and served as Vice President from February 2014 through December 2014and on the board of directors from April 2014 through October 2014. At Medbox, Inc. Mr. Feinstein responsibilities included developing client relationships and assisting these clients through the licensing process for canna-businesses. Upon securing a license, he would manage the process of site selection, site construction, and training for each client. During his tenure, Feinstein assisted clients to secure canna-business licenses in Nevada, California, Washington, Oregon, and Illinois. He resigned as Chief Financial Officer on March 15, 2016.

Mr. Feinstein has over 27 years of experience in consumer product manufacturing, distribution, and national retail operations. He served as the Director of Technical Service Operations at Minute Key, Inc. from 2011 to 2012, Operational Supervisor at Redbox, Inc. from 2009 to 2011, President and founder of Starlight Home Entertainment, a leading independent DVD sales, marketing, and distribution company from 2001 to 2008, Managing Director of Consumer Services at Urbanfetch from 1999 to 2000, and Vice President of the Franchisor Military Rent-All and Marbles Entertainment retail chains from 1991 to 1999.Mr. Feinstein and Starlight Home Entertainment separately filed bankruptcy petitions in 2007. The bankruptcies were discharged in 2008. Mr. Feinstein earned his undergraduate degree in Political Science in 1991 from the University of California, Berkeley. Mr. Feinstein’s background and many years of experience in retail operations and rolling out retail chains provides the Company with experience and knowledge in this area. When combining these duties with his added and more recent experience in the cannabis industry and his ability to source investors for the Company, Mr. Feinstein lends himself to be an ideal candidate to head the Company and serve on the Board as its Chairman at the critical and early stages of the Company’s lifecycle.

Theresa Flynt. Ms. Flynt oversees the development of new and existing consulting businesses, in addition to assisting the company in its licensing and branding efforts. Ms. Flynt has over 20 years of experience in operations, management, marketing, licensing, and development. Prior to joining Pineapple Express, Ms. Flynt spent 21 years working at Hustler in various roles. She started in Hustler’s publishing division. She went on to oversee the design, building and day-to-day operations of Hustler Hollywood, a retail powerhouse with 15 locations nationwide. She later moved on to becoming Hustler’s Executive Vice President of Retail Operations, Vice President of Licensing and Brand Development and, then, Chief Marketing Officer. Ms. Flynt earned her bachelorette degree in Business Administration, Marketing and Management from Mount Saint Mary’s University in Los Angeles, CA. She has also served on the boards of FSC (Free Speech Coalition), ASACP (Association of Sites Advocating Child Protection), and FMG (Flynt Management Group for the Hustler brand).

Eric Kennedy. Mr. Kennedy was appointed to our board of directors on June 1, 2016. Since June 2013, Mr. Kennedy has been a partner in the Los Angeles office of a regional law firm with offices in California, Utah, Nevada, and Arizona. From April 2010 to June 2013, Mr. Kennedy was an attorney with the international law firm, Jones Day. Mr. Kennedy’s practice focuses primarily on representing public companies and large private companies in all aspects of commercial litigation, including class action defense and disputes involving contracts, fraud, unfair competition, real estate, false advertising, trade secrets, and trademark and copyright infringement. Mr. Kennedy was defense counsel in a four month trial regarding the fiduciary duties applicable to the members of a board of directors. In the process of obtaining a full defense verdict for his client, Mr. Kennedy gained valuable experience and knowledge regarding the critical role of directors, including their collective and individual duties to the company and the shareholders. He brings that experience with him to the Company’s board. Mr. Kennedy obtained his BS in Psychology from Brigham Young University in 1999 and his JD from the University of Southern California in 2003. Mr. Kennedy has the experience and understating of the environment that present day public companies must operate in. He brings a unique legal perspective and insights specifically regarding the duties and roles that board members must follow to faithfully uphold their obligations and his service as an independent director should be of great value to the Company.

Family Relationships

There are no family relationships between any of our officers and directors.

Item 6. Executive Compensation.

Our named executive officers, consisting of our principal executive officer and our only other executive officer as of December 31, 2016 (the “Named Executive Officers”), were:

Consulting Agreements, Employment Agreements and Other Arrangements

Matthew Feinstein ― We paid Matthew Feinstein, our Chief Executive Officer, President, Secretary and Chairman of the Board of Directors, a total of $64,000 from February 2015 through August 31, 2015. On August 24, 2015, we entered into a two-year consulting agreement with Mr. Feinstein. Pursuant to this agreement, we paid Mr. Feinstein $12,000 in September 2015, and a monthly fee of $15,000 in October 2015, and thereafter to be available to provide at least 30 hours of consulting services a week on matters including (i) state, county and city marijuana statutes, rules, laws and relationships and (ii) the operation of medical marijuana dispensaries, including implementation of internal controls and asset safeguards, growing facility management and crop optimization, multi-location product distribution and controls, cash collection security and processing controls and inventory management for just-in-time dispensary deliveries. We also agreed to issue Mr. Feinstein 500,000 shares of Series A Convertible Preferred Stock that are convertible into 5,000,000 shares of our common stock. The issuance of the 500,000 shares of Series A Convertible Preferred Stock was rescinded effective December 31, 2015.

On March 1, 2016, we entered into an employment agreement with Mr. Feinstein and terminated the consulting agreement. The agreement has a 13-month term and provides for an annual base salary of $180,000. Mr. Feinstein shall be eligible for performance-based bonuses and equity awards at the sole discretion of the Company. The agreement may be terminated by either party for any reason with two weeks’ notice; provided however, we may terminate the agreement for cause with no notice, and provided further that Mr. Feinstein may terminate the agreement for good reason but only after providing written notice to us identifying in reasonable detail the basis therefor and delivered within 30 days after his actual knowledge of the event or circumstance providing such basis, and the Company has not cured such condition within 45 days following delivery of such written notice. In the event that Mr. Feinstein terminates his employment with or without cause or the Company terminates Mr. Feinstein’s employment without cause, Mr. Feinstein shall be entitled to receive a severance payment of $180,000 in one lump sum. The agreement requires that Mr. Feinstein ensure that no conflict of interest arises with respect to his transactions with any other entity during the term of the agreement. He is also required to never disclose any confidential material acquired during the course of his service, subject to customary exceptions, and, for a period extending to one year following his resignation or removal, own, manage, advise or finance any entity or person engaged in the Cannabis industry or in competition with the Company. On January 1, 2017 Mr. Feinstein terminated his employment agreement in favor of a consulting agreement.

Theresa Flynt

On November 30, 2015, we entered into a consulting agreement with Theresa Flynt. The agreement had a term of three months and could be terminated by Ms. Flynt with 30 days prior written notice. Pursuant to this agreement, we paid Ms. Flynt a monthly fee of $7,500 and 100,000 shares of the Company. On March 1, 2016, we entered into an employment agreement with Ms. Flynt to appoint her as Vice President, Business Development of the Company. Pursuant to this agreement, we agreed to pay Ms. Flynt an annual salary of $120,000 and 100,000 restricted shares of the Company’s common stock.

Director Compensation for Fiscal Year Ended December 31, 2016

In June 2016, we entered into an Independent Director Retention Agreement with Eric Kennedy. Pursuant to this agreement we agreed to pay Mr. Kennedy cash compensation of $1,500 per month throughout the term of his service. We also agreed to issue him 50,000 shares of our common stock upon his appointment and an additional 2,500 shares following the end of each calendar quarter through the term of his service. On January 26, 2017, the Company issued Mr. Kennedy 75,000 additional shares as an additional benefit of his continued engagement on our Board of Directors.

Outstanding Equity Awards at Fiscal Year-End

We did not have any equity awards outstanding as of December 31, 2016.

Item 7. Certain Relationships and Related Transactions, and Director Independence.

Certain Relationships and Related Transactions

From January 29, 2015 (date of inception) through December 31, 2015, BBC and the Company issued demand notes to related party entities for advances in aggregate of $305,000. We did not incur any interest or fees in connection with these notes. As of December 31, 2015, $42,000 was outstanding. As of March 14, 2017, BBC owes Sky Island, Inc., $560,000 pursuant to an interest-bearing note that bears an interest rate of 10% per year and will mature on December 31, 2021. The note is due and payable on demand.

In August 2015, we issued 500,000 shares of Series A Convertible Preferred Stock to Matthew Feinstein, our Chief Executive Officer, President, Secretary and Chairman of the Board, pursuant to a consulting agreement. The shares were rescinded pursuant to a rescission agreement effective December 31, 2015.

In September 2015 we issued 100,000 shares of Series A Convertible Preferred Stock to Christopher Plummer, our Chief Compliance Officer and a director, pursuant to a consulting agreement. The shares were rescinded pursuant to a rescission agreement effective December 31, 2015.

In August 2015 we were assigned the provisional patent application for the “Top-Shelf” display safe system. The system allows for a dispensary operator to safely display product, secure product in an armored safe, weigh product in real-time using electronic scales housed in each of the locked compartments within the safe, and then dispense the product using an integrated Point-of-Sale, or POS System. On July 20, 2016 we entered into a licensing and royalty agreement with the developer of the “Top-Shelf” (“Assignor”), Sky Island, Inc., which is owned by our largest shareholder Jaime Ortega and, which assigned us the patent application in question and provided for a royalty arrangement with Assignor pursuant to which (i) the Company shall pay Assignor a one-time royalty payment equal to 30% of the gross sales price of each unit sold, and (i) if a system is leased, the Company shall pay Assignor 30% of any lease payments made to the Assignee. On May 9, 2017 the USPTO published the approved patent (#9,642,476) for the “Top-Shelf” system.

During the period from January 29, 2015 through December 31, 2015, the Company purchased a 15.18% ownership interest in Nature’s Treatment of the Quad Cities, LLC NTQC Series II (“Series II”) and NTI, both companies founded by Mr. Feinstein, for an aggregate investment of $162,214.Series II is expected to own a building that will house dispensary operations of NTI. Mr. Feinstein transferred his interests in NTQC and NTI to BBC in 2015 for $50,000, $45,000 of which is still owed to Mr. Feinstein. In connection with the investment, the Company, through BBC, entered into a consulting agreement whereby the Company will provide consulting and managerial services in exchange for the lesser of 5% of NTI’s gross profit or 15.18% of the after-tax distributable income of NTI. The consulting agreement has a five year term with an automatic five year renewal period unless terminated upon 30 days’ notice prior to end of current term by either party.

Throughout 2016 and 2017, the Company entered into a series of promissory notes to borrow a total of approximately$1.4 million from Sky Island Inc., which is owned by our largest shareholder Jaime Ortega.

Director Independence

Our Board of Directors presently consists of two members. Our Board of Directors has determined that Eric Kennedy is the only “independent” director as such term is defined by SEC rules adopted pursuant to the requirements of the Sarbanes-Oxley Act of 2002 and as determined in accordance with Rule 4200(a)(15) of the Marketplace Rules of the NASDAQ Stock Market, Inc.

Item 8. Legal Proceedings.

From time to time we may be involved in litigation relating to claims arising out of the operation of our business in the normal course of business. Except as set forth below, as of the date of this registration statement we are not aware of potential dispute or pending litigation and are not currently involved in a litigation proceeding or governmental actions the outcome of which in management’s opinion would be material to our financial condition or results of operations. An adverse result in these or other matters may have, individually or in the aggregate, a material adverse effect on our business, financial condition or operating results.

A trademark application was filed by Global Brand Consulting LLC for a logo including the word “THC” (the “Conflicting Trademark”) with the USPTO. We believe that this application should have been rejected by the USPTO in light of the existing registered THC® trademark and that any use in commerce of the Conflicting Trademark by Global Brand Consulting LLC would be an infringement upon our trademark. We and the THC shareholders have agreed to hold in escrow $150,000 of the purchase price paid to the THC shareholders for use in connection with resolving this trademark dispute. As of June 15, 2016, we have delivered a cease and desist letter to Global Brand Consulting LLC in connection with the foregoing. The Company has not yet initiated a lawsuit to pursue any infringement claims we might have with regard to the THC trademark.

DHS Project/Pineapple Park

On March 14, 2017, the Company entered into a Share Purchase Agreement to sell BBC and its three wholly owned subsidiaries, Pineapple Express One LLC, Pineapple Express Two LLC and Pineapple Property Investments, LLC to a related party, Jaime Ortega. Mr. Ortega expressed interest in these companies so that he can fund and prosecute litigation claims and settle debts for these subsidiaries, resulting from unconsummated parcel purchases the Company feels was purposely circumvented by 3 ^rd parties involved in those transactions. Mr. Ortega, as an interested party, took these steps so the Company’s claims can be addressed against the parties at fault without negatively impacting or distracting the Company. The terms of the Share Purchase Agreement are discussed in greater detail in the “legal proceedings” section of this Form 10.

Legal Actions/DHS Project/Pineapple Park

On April 7, 2017, Orr Builders, Prest-Vuksic Architects, Inc. and MSA Consulting, Inc. (all California corporations) (as Plaintiffs) filed a complaint upon the Company, including subsidiaries Pineapple Express One LLC, Better Business Consultants Inc., and MJ Business Consultants; Clonenetics Laboratories Cooperative, Inc.; United Pentecostal Church; and Healing Nature, LLC; and numerous DOES 1 through 100 (as Defendants) in the Superior Court of the State of California for the County of Riverside, Case No. PSC 1700746 (hereinafter referred to as the “Lead Case”), and a related and consolidated case #PSC1702268, alleging, among other things: (i) breaches of contracts related to the DHS Project/Pineapple Park, (ii) foreclosure of mechanics’ lien, (iii) negligent misrepresentation, and (4) unjust enrichment (against United Pentecostal Church only).

This matter is currently in initial discover stage. A hearing for judgment on the pleadings on the Lead Case is set for December 5, 2017. A Trial Setting Conference is set for January, 2018. Currently, the matter is an active litigation and with discovery just underway, it is unclear whether the matter will be settled or go to trial.

An additional complaint was filed by Searock+Stafford CM, a construction management firm engaged for various aspects of the DHS Project, Case #BC658092 that was settled and dismissed on September 26, 2017.

BBC/PE2 – DHS Project/Pineapple Park Counter Complaint

Former subsidiary, Better Business Consultants, Inc., sold to the Company’s largest shareholder, Jaime Ortega on March 14, 2017, have filed a complaint against Clonenetics Laboratories Cooperative, Inc. (“CLC”) and its CEO, Dan Osborne (“Osborne”), entities heretofore named as co-defendants in the complaint filed on the Company by Orr Builders, et. al. on April 7, 2017 (the Lead Case), for breach of contract in an amount of $116,433 for promissory notes executed by CLC and guaranteed by Osborne on March 25, 2016 (Case No. SC127739). The matter is currently in discovery stage, however counsel for CLC has advised a motion for substitution of attorney will be filed.

Prior to April 28, 2016, our common stock was quoted on the OTCPink Marketplace. On April 28, 2016 the SEC suspended the trading of our Common Stock due to market activity that raised concerns about the adequacy of publicly-available information regarding the Company. The trading suspension ended on May 11, 2016 but a broker must also file a Form 15c2-11 with FINRA that must be approved before the Common Stock can be eligible for quotation on the OTCPink Marketplace. As of the date of this Form 10, no broker has filed a Form 15c2-11 and as a result, our Common Stock trades on the OTC Grey Market. On March 31, 2016 the OTC Markets Group identified our securities with a caveat emptor symbol due to trading activity that caused our stock price to rise from a low of $10.10 on March 24, 2016 to a high of $42.38 on March 31, 2016.The caveat emptor symbol is intended to inform investors that there may be reason to exercise additional care and perform thorough due diligence in making investment decisions in an issuer. We anticipate that a broker will file a Form 15c2-11 and that such form will be approved and that the caveat emptor will be removed after we file this Form 10 with the Securities and Exchange Commission (“SEC”) and the Form 10 has cleared the SEC’s comments. Should the SEC refuse to clear comments on the Form 10 or the OTC Markets Group refuse to remove the caveat emptor symbol, our Common Stock may never be able to uplist from the OTC Grey Sheets, the trading price of our Common Stock could suffer, the trading market for our Common Stock may be less liquid and our stock price may be subject to increased volatility, making it difficult or impossible for you to resell shares of our Common Stock.

Item 9. Market Price of and Dividends on the Registrant’s Common Equity and Related Stockholder Matters.

Our Common Stock is currently eligible for quotation and trades on the OTC Grey Market under the symbol “PNPL.” On March 31, 2016, the OTC Markets Group identified our securities with a caveat emptor symbol due to trading activity that caused our stock price to rise from a low of $10.10 on March 24, 2016 to a high of $42.38 on March 31, 2016.

The following table sets forth the high and low closing bid prices for our common stock for the fiscal quarter indicated as reported on OTCPink Marketplace and OTC Grey Market, as applicable. The quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not represent actual transactions. Our common stock is very thinly traded and, thus, pricing of our common stock on the OTC Grey Market does not necessarily represent its fair market value. The last reported sales price of our common stock on the OTC Grey Market on January 19, 2018 was $1.15 per share.

Holders

As of December 31, 2017, we had 64,220,425 shares of common stock outstanding and approximately 247 shareholders of record.

Dividend Policy

We have never paid any cash dividends on our capital stock and do not anticipate paying any cash dividends on our Common Stock in the foreseeable future. We intend to retain future earnings to fund ongoing operations and future capital requirements. Any future determination to pay cash dividends will be at the discretion of our Board of Directors and will be dependent upon financial condition, results of operations, capital requirements and such other factors as the Board of Directors deems relevant.

Securities Authorized for Issuance under Equity Compensation Plans

We do not have any common stock authorized for issuance under equity compensation plans.

Item 10. Recent Sales of Unregistered Securities.

The following information represents securities sold by the Company within the past three years which were not registered under the Securities Act. Included are sales of reacquired securities, as well as new issues, securities issued in exchange for property, services, or other securities, and new securities resulting from the modification of outstanding securities.

Item 11. Description of Registrant’s Securities to be Registered.

Common Stock

This Form 10 relates to our common stock, $0.0000001 par value per share (the “Common Stock”). We are authorized to issue 500,000,000 shares of Common Stock, and 20,000,000 shares of preferred stock, par value $0.0000001(the “Preferred Stock”). As of December 31, 2017, there were 64,220,425 shares of Common Stock and 0 shares of Preferred Stock outstanding.

The holders of our Common Stock have equal ratable rights to dividends from funds legally available therefore, when, as and if declared by our board of directors. Holders of Common Stock are also entitled to share ratably in all of our assets available for distribution to holders of Common Stock upon liquidation, dissolution or winding up of the affairs.

Certain shares of Common Stock held by our affiliates, employees and consultants, or approximately 73% of our total shares of Common Stock issued and outstanding as of December, 2017, are subject to two-year lockup agreements restricting future sales. The lock-up agreements generally provide for restrictions on the resale of shares in the public market and will expire in during the period between August 2017 and March 2018. Our largest shareholder, Jaime Ortega, is locked up from public market resale of his shares for a longer period of time based on his lockup agreement.

The holders of shares of our Common Stock do not have cumulative voting rights, which means that the holders of more than 50% of such outstanding shares, voting for the election of directors, can elect all of the directors to be elected, if they so choose and in such event, the holders of the remaining shares will not be able to elect any of our directors. The holders of 50% percent of the outstanding Common Stock constitute a quorum at any meeting of shareholders, and the vote by the holders of a majority of the outstanding shares or a majority of the shareholders at a meeting at which quorum exists are required to effect certain fundamental corporate changes, such as liquidation, merger or amendment of our articles of incorporation.

Holders of our Common Stock may resell their shares of Common Stock, pursuant to Rule 144 under the Securities Act (“Rule 144”), one year following the date of acquisition of such securities from the Company until such time that the Company becomes subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act. Holders of our Common Stock may resell their shares of Common Stock, pursuant to Rule 144 six months following the date of acquisition of such securities from the Company or an affiliate of the Company after the Company has been subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act, for a period of at least 90 days immediately before such sale, and has filed all required reports under the Exchange Act (other than reports on Form 8-K) during the preceding 12 months (or such shorter period as the Company was required to file such reports). If the condition set forth above relating to the Company having filed all required reports under the Exchange Act is not satisfied, holders of our Common Stock may resell their shares of Common Stock, pursuant to Rule 144, one year following the acquisition of such securities from the Company or an affiliate of the Company.

Shares of our Common Stock are registered at the office of the Company and are transferable at such office by the registered holder (or duly authorized attorney) upon surrender of the Common Stock certificate, properly endorsed. No transfer shall be registered unless the Company is satisfied that such transfer will not result in a violation of any applicable federal or state securities laws.

Preferred Stock

We have authority to issue 20,000,000 shares of “blank check” Preferred Stock. Our Board of Directors may issue the authorized Preferred Stock in one or more series and may fix the number of shares of each series of preferred stock. Our Board of Directors also has the authority to set the voting powers, designations, preferences and relative, participating, optional or other special rights of each series of Preferred Stock, including the dividend rights, dividend rate, terms of redemption, redemption price or prices, conversion and voting rights and liquidation preferences. Preferred Stock can be issued and its terms set by our Board of Directors without any further vote or action by our stockholders.

Series A Preferred Stock

As of December 31, 2017, there were no shares of Series A Preferred Stock issued and outstanding.

Dividends

We have not paid any cash dividends to our shareholders. The declaration of any future cash dividends is at the discretion of our Board of Directors and depends upon our earnings, if any, our capital requirements and financial position, our general economic conditions, and other pertinent conditions. It is our present intention not to pay any cash dividends in the foreseeable future, but rather to reinvest earnings, if any, in our business operations.

Stock Transfer Agent

Our transfer agent is Standard Registrar and Transfer Company, Inc., 440 East 400 South, Suite 200, Salt Lake City, UT84111.

Item 12. Indemnification of Directors and Officers.

Indemnification of Directors and Officers

The Corporation Law of the State of Wyoming and the Company’s Bylaws provide for indemnification of our directors, officers, employees and agents (collectively, the “Covered Persons”) to for liabilities and expenses that they may incur in such capacities. In general, the Covered Persons may be indemnified with respect to actions taken in good faith and in a manner that the Covered Person reasonably believed to be in the best interest of the Company, and, in the case of a criminal proceeding, had no reasonable cause to believe his conduct was unlawful.

Regarding indemnification for liabilities arising under the Securities Act, which may be permitted to directors or officers under Wyoming law, we are informed that, in the opinion of the SEC, such indemnification is against public policy, as expressed in the Securities Act and is, therefore, unenforceable.

We have not entered into any agreements with our directors and executive officers that require us to indemnify these persons against expenses, judgments, fines, settlements and other amounts actually and reasonably incurred (including expenses of a derivative action) in connection with any proceeding, whether actual or threatened, to which any such person may be made a party by reason of the fact that the person is or was a director or officer of our Company or any of our affiliated enterprises.

We do not maintain any policy of directors’ and officers’ liability insurance that insures its directors and officers against the cost of defense, settlement or payment of a judgment under any circumstances.

Item 13: Financial Statements and Supplementary Data.

PINEAPPLE EXPRESS, INC.

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

See accompanying notes to these unaudited condensed consolidated financial statements.

See accompanying notes to these unaudited condensed consolidated financial statements.